molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles,pActivity
CHEMBL2093896,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL660921,B,Blockade of Na+ current in frog oocytes expressing human cardiac sodium channel (HH1),CHEMBL1128716,IC50,CSc1ccc([C@H]2N=C(OCc3ccc(NS(C)(=O)=O)cc3)N(C)Cc3ccccc32)cc1.Cl,4.522878745280337
CHEMBL1788206,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,126000.0,nM,CHEMBL805186,B,Blockade of Na+ current in frog oocytes expressing human cardiac sodium channel (HH1),CHEMBL1128716,IC50,CN1Cc2ccccc2[C@@H](c2ccccc2)N=C1OCc1ccc(NS(C)(=O)=O)cc1.O=C(O)/C=C/C(=O)O,3.8996294548824375
CHEMBL106610,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3600.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCCCCc2ccccc2)cc1,5.443697499232712
CHEMBL110572,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4100.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1cccc2ccccc12,5.3872161432802645
CHEMBL432963,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9000.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,CCCC/N=C(/N)NC(=O)c1ccc(C)cc1,5.045757490560675
CHEMBL109012,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2710.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1cccc(Cl)c1Cl,5.567030709125595
CHEMBL431643,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7890.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1cc(Cl)ccc1Cl,5.10292299679058
CHEMBL108070,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10500.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCc2cccs2)cc1,4.978810700930062
CHEMBL105929,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4500.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)N/C(N)=N\c2ccccc2C(C)C)cc1,5.346787486224656
CHEMBL108347,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,560.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,CCCCOc1ccc(C(=O)NC(=N)NCCCCc2ccccc2)cc1,6.251811972993799
CHEMBL107354,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5650.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCc2ccccc2)cc1,5.247951552180561
CHEMBL108782,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5600.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCCOc2ccccc2)cc1,5.251811972993799
CHEMBL106459,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1750.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccccc1C(=O)NC(=N)NCCCCc1ccccc1,5.756961951313706
CHEMBL108627,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8850.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCc2cccc3ccccc23)cc1,5.053056729302174
CHEMBL110164,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1510.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,COc1cc(C(=O)NC(=N)NCCCCc2ccccc2)cc(OC)c1OC,5.821023052706831
CHEMBL322599,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3600.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1ccc(Cl)cc1,5.443697499232712
CHEMBL322055,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9000.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,C/N=C(\NCCCCc1ccccc1)NC(=O)c1ccc(C)cc1,5.045757490560675
CHEMBL110352,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5400.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1c(Cl)cccc1Cl,5.267606240177031
CHEMBL107394,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19700.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)Nc2ccc(C(C)C)cc2)cc1,4.705533773838407
CHEMBL421032,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1760.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,COc1ccc2[nH]cc(CC/N=C(/N)NC(=O)c3ccc(C)cc3)c2c1,5.75448733218585
CHEMBL105997,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5250.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCCc2ccccc2)cc1,5.279840696594043
CHEMBL320332,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8500.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCc2ccc(Cl)cc2)cc1,5.070581074285707
CHEMBL106351,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5750.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)Nc2ccc(OC(C)C)cc2)cc1,5.2403321553103694
CHEMBL105782,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,24350.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,COc1cc(NC(=N)NC(=O)c2ccc(C)cc2)cc(OC)c1OC,4.613501034449347
CHEMBL320314,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3920.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,COc1cccc2[nH]cc(CC/N=C(/N)NC(=O)c3ccc(C)cc3)c12,5.406713932979542
CHEMBL107684,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15500.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1ccc(Cl)c(Cl)c1,4.809668301829708
CHEMBL106356,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14200.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCOc2ccccc2)cc1,4.847711655616943
CHEMBL321883,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2100.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,COc1ccc(C(=O)NC(=N)NCCCCc2ccccc2)cc1,5.6777807052660805
CHEMBL108361,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2350.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1cccs1,5.628932137728263
CHEMBL108728,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2850.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCCCc2ccccc2)cc1,5.54515513999149
CHEMBL108727,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,CCOc1ccc(C(=O)NC(=N)NCCCCc2ccccc2)cc1,5.958607314841775
CHEMBL109127,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7900.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,N=C(NCCCCc1ccccc1)NC(=O)c1ccco1,5.102372908709558
CHEMBL320248,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10800.0,nM,CHEMBL660922,B,Inhibition of sodium channel blockade in CHO cells expressing human cardiac (hHI) sodium channel,CHEMBL1134151,IC50,Cc1ccc(C(=O)NC(=N)NCCSCc2ccccc2)cc1,4.966576244513051
CHEMBL208957,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,60000.0,nM,CHEMBL868205,B,Inhibition of human cardiac sodium channel,CHEMBL1148642,IC50,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3nccc3n2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,4.221848749616356
CHEMBL387671,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4000.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,c1ccc2c(CCO[C@@H]3CCCC[C@H]3N3CCOCC3)cccc2c1,5.3979400086720375
CHEMBL79,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,108000.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,CCN(CC)CC(=O)Nc1c(C)cccc1C,3.9665762445130506
CHEMBL652,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6500.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,5.187086643357144
CHEMBL1294,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6900.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,5.161150909262744
CHEMBL375475,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,O=C1CCN([C@H]2CCCC[C@@H]2OCCc2cccc3ccccc23)C1,4.886056647693163
CHEMBL229125,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11000.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,O=C1CCN([C@@H]2CCCC[C@H]2OCCc2cccc3ccccc23)C1,4.958607314841775
CHEMBL229125,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25000.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,O=C1CCN([C@@H]2CCCC[C@H]2OCCc2cccc3ccccc23)C1,4.6020599913279625
CHEMBL387935,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15000.0,nM,CHEMBL905110,B,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL1143695,IC50,Clc1ccc(CCO[C@@H]2CCCC[C@H]2N2CCOCC2)cc1Cl,4.823908740944319
CHEMBL250699,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7440.0,nM,CHEMBL926143,B,Inhibition of inactivated human Nav1.5 sodium channel,CHEMBL1141460,IC50,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1,5.128427064454121
CHEMBL250699,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,32820.0,nM,CHEMBL931280,B,Inhibition of human Nav1.5 channel expressed in HEK293 cells at -150 mV by patch clamp method,CHEMBL1142222,IC50,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1,4.483861423282925
CHEMBL250699,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7340.0,nM,CHEMBL931281,B,Inhibition of human Nav1.5 channel expressed in HEK293 cells at -90 mV by patch clamp method,CHEMBL1142222,IC50,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1,5.13430394008393
CHEMBL521211,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4600.0,nM,CHEMBL954009,B,Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL1150418,IC50,O=C(c1ccc(-c2ccc(Cl)cc2)o1)N1CCNCC1,5.337242168318426
CHEMBL741,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,62000.0,nM,CHEMBL954009,B,Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL1150418,IC50,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,4.2076083105017466
CHEMBL558,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL954009,B,Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL1150418,IC50,Cc1cccc(C)c1OCC(C)N,4.886056647693163
CHEMBL486495,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,100.0,nM,CHEMBL954009,B,Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL1150418,IC50,CC(C)(C)c1ccc(-c2ccc(C(=O)N3CCN(C4CCCCC4)CC3)o2)cc1,7.0
CHEMBL482676,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2300.0,nM,CHEMBL954009,B,Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL1150418,IC50,O=C(c1ccc(-c2ccc(Cl)cc2)o1)N1CCN(C2CCCCC2)CC1,5.638272163982407
CHEMBL488817,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,84000.0,nM,CHEMBL939609,B,Inhibition of sodium channel Nav1.5 by voltage-clamp method,CHEMBL1157496,IC50,CC1(C)C[C@@H](CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1,4.075720713938118
CHEMBL511058,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2560.0,nM,CHEMBL962062,B,Inhibition of sodium Nav1.5 channel assessed as inhibition of late sodium current elicited at -30 mV from holding potential of -110 mV,CHEMBL1157462,IC50,COc1ccccc1SC[C@@H](C)CN[C@@H]1COc2ccccc2SC1,5.59176003468815
CHEMBL511058,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5770.0,nM,CHEMBL962063,B,Inhibition of sodium Nav1.5 channel assessed as inhibition of late sodium current elicited at -30 mV from holding potential of -90 mV,CHEMBL1157462,IC50,COc1ccccc1SC[C@@H](C)CN[C@@H]1COc2ccccc2SC1,5.238824186844269
CHEMBL495601,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1000.0,nM,CHEMBL1001516,B,Inhibition of Voltage-gated sodium channel subunit alpha Nav1.5,CHEMBL1137005,IC50,O=C1CC2(CCN(C(=O)NC3CCc4ccccc4C3)CC2)Oc2ccccc21,6.0
CHEMBL552402,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL1053972,B,Inhibition of Nav1.5 channel,CHEMBL1152451,IC50,O=C(NC1CC1c1ccccc1)N1CCC(c2nc3ccccc3o2)CC1,5.0
CHEMBL1080975,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL1100152,B,Inhibition of Nav1.5 channel,CHEMBL1154229,IC50,CC1(c2ccccc2)CCCN(C(=O)NCc2ccc(-c3cccc(Cl)c3)cc2)C1,5.0
CHEMBL1270208,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4700.0,nM,CHEMBL1272891,B,Inhibition of human NaV1.5 by electrophysiology,CHEMBL1268885,IC50,O=C(NCc1cccnc1OCC(F)(F)F)c1cncc(-c2ccc(Cl)cc2)c1,5.327902142064282
CHEMBL1631095,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1320.0,nM,CHEMBL1633012,B,Inhibition of Nav1.5 by VIPR assay,CHEMBL1629455,IC50,NC(=O)c1cc(C(N)=O)n(-c2cccc(-c3cc(C(F)(F)F)ccc3C(F)(F)F)c2)n1,5.8794260687941495
CHEMBL1797413,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12022.64,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1cccc(C)c1-c1noc(C)c1CC(=O)NCc1cccc(OCCOCC(F)(F)F)n1,4.920000156997057
CHEMBL1797409,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4677.35,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1CC(=O)NCc1ccc(OC(C)C)nc1,5.330000131185909
CHEMBL1797405,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19952.62,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1cccc(C)c1-c1noc(C)c1NC(=O)NCc1ccc(OC(C)C)nc1,4.70000006855703
CHEMBL1797402,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5888.44,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1N(C)C(=O)NCc1ccc(OC2CCOCC2)nc1,5.229999745811778
CHEMBL1797400,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8511.38,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)NCc1c(F)cccc1Cl,5.070000019492822
CHEMBL1797399,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7762.47,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1cccc(C)c1-c1noc(C)c1NC(=O)OCc1c(F)cccc1Cl,5.110000065251387
CHEMBL1797395,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7244.36,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,CCc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1c(F)cccc1Cl,5.139999976065226
CHEMBL1797392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1348.96,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1ccc(OC2CCCC2)nc1,5.8700009280425745
CHEMBL1797391,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8709.64,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1ccc(OC(C)C)nc1,5.059999795537068
CHEMBL1797389,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2630.27,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1cc(Cl)ccc1Cl,5.579999668433626
CHEMBL1797388,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8709.64,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1ccccc1Cl,5.059999795537068
CHEMBL1797387,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5495.41,nM,CHEMBL1799748,B,Inhibition of Nav1.5 by cell based whole-cell voltage clamp electrophysiology assay,CHEMBL1795246,IC50,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1c(F)cccc1Cl,5.259999900311453
CHEMBL1813048,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL1816265,B,Inhibition of 20% inactivated TTX-resistant human sodium channel Nav1.5 expressed in human HEK293 cells at 1 uM by patch-clamp electrophysiological assay,CHEMBL1811851,IC50,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(OC(F)(F)F)cc4)CC3)n2)c1C,5.958607314841775
CHEMBL1813048,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5200.0,nM,CHEMBL1816131,B,Inhibition of human cardiac sodium channel Nav1.5 expressed in human HEK293 cells by patch-clamp electrophysiological assay,CHEMBL1811851,IC50,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(OC(F)(F)F)cc4)CC3)n2)c1C,5.2839966563652006
CHEMBL1813042,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6800.0,nM,CHEMBL1816131,B,Inhibition of human cardiac sodium channel Nav1.5 expressed in human HEK293 cells by patch-clamp electrophysiological assay,CHEMBL1811851,IC50,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(C(F)(F)F)cc4)CC3)n2)c1C,5.167491087293763
CHEMBL1813050,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,300.0,nM,CHEMBL1816131,B,Inhibition of human cardiac sodium channel Nav1.5 expressed in human HEK293 cells by patch-clamp electrophysiological assay,CHEMBL1811851,IC50,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)n2)c1C,6.522878745280337
CHEMBL1813049,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,500.0,nM,CHEMBL1816131,B,Inhibition of human cardiac sodium channel Nav1.5 expressed in human HEK293 cells by patch-clamp electrophysiological assay,CHEMBL1811851,IC50,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(Oc4ccc(C(F)(F)F)cc4)CC3)n2)c1C,6.301029995663981
CHEMBL1813015,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5400.0,nM,CHEMBL1816131,B,Inhibition of human cardiac sodium channel Nav1.5 expressed in human HEK293 cells by patch-clamp electrophysiological assay,CHEMBL1811851,IC50,CC(=O)Nc1cccc(Nc2ncnc(N3CCc4ccccc4C3)n2)c1,5.267606240177031
CHEMBL631,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3300.0,nM,CHEMBL1918926,B,Inhibition of human cloned Nav1.5 channel expressed in chinese hamster CHO cells assessed as tonic inhibition after 5 mins by patch clamp assay,CHEMBL1914304,IC50,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,5.481486060122112
CHEMBL1958460,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5780.0,nM,CHEMBL1959242,B,Inhibition of human voltage-gated sodium channel 1.5 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis,CHEMBL1955838,IC50,CCCCCCCC(O)(C(N)=O)c1cccc(Cl)c1,5.2380721615794705
CHEMBL1958461,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7430.0,nM,CHEMBL1959242,B,Inhibition of human voltage-gated sodium channel 1.5 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis,CHEMBL1955838,IC50,CCCCCCC[C@](O)(C(N)=O)c1cccc(Cl)c1,5.129011186239425
CHEMBL1958462,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4780.0,nM,CHEMBL1959242,B,Inhibition of human voltage-gated sodium channel 1.5 expressed in HEK293 cells assessed as changes in membranre potential after 45 mins by FRET analysis,CHEMBL1955838,IC50,CCCCCCC[C@@](O)(C(N)=O)c1cccc(Cl)c1,5.320572103387882
CHEMBL558,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,420000.0,nM,CHEMBL2020459,B,Blockade of human full-length NaV1.5 expressed in HEK293 cells co-transfected with pCD8-IRES-hbeta1 assessed as 0.1 Hz of half-maximal tonic-induced channel current at -120 mV holding potential after 36 to 72 hrs by patch clamp assay,CHEMBL2016510,IC50,Cc1cccc(C)c1OCC(C)N,3.376750709602099
CHEMBL2018453,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,174000.0,nM,CHEMBL2020459,B,Blockade of human full-length NaV1.5 expressed in HEK293 cells co-transfected with pCD8-IRES-hbeta1 assessed as 0.1 Hz of half-maximal tonic-induced channel current at -120 mV holding potential after 36 to 72 hrs by patch clamp assay,CHEMBL2016510,IC50,Cc1ccc(O)c(C)c1OCC(C)N,3.7594507517174005
CHEMBL558,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,58000.0,nM,CHEMBL2020460,B,Blockade of human full-length NaV1.5 expressed in HEK293 cells co-transfected with pCD8-IRES-hbeta1 assessed as 10 Hz of use-dependent-induced channel current at -120 mV holding potential after 36 to 72 hrs by patch clamp assay,CHEMBL2016510,IC50,Cc1cccc(C)c1OCC(C)N,4.236572006437063
CHEMBL2018453,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL2020460,B,Blockade of human full-length NaV1.5 expressed in HEK293 cells co-transfected with pCD8-IRES-hbeta1 assessed as 10 Hz of use-dependent-induced channel current at -120 mV holding potential after 36 to 72 hrs by patch clamp assay,CHEMBL2016510,IC50,Cc1ccc(O)c(C)c1OCC(C)N,4.522878745280337
CHEMBL2069400,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1995.26,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(OC(F)(F)F)cc2)CO3)CC1,5.700000503883016
CHEMBL2069401,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)CC1,5.300000202445418
CHEMBL2069402,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(OCCC(F)(F)F)nc2)CO3)CC1,5.300000202445418
CHEMBL2069403,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,Cc1nn(-c2ccccc2)nc1C(=O)N[C@@H]1COc2cccc(N3CCN(C)CC3)c2C1,5.300000202445418
CHEMBL2069404,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2511.89,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,Cc1ccc(-n2nc(C)c(C(=O)N[C@@H]3COc4cccc(N5CCN(C)CC5)c4C3)n2)c(C)c1,5.59999938302362
CHEMBL2069406,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3162.28,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3cccnc3)c2C1)c1ccc(OC(F)(F)F)cc1,5.499999678657065
CHEMBL2069407,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3981.07,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3ccncc3)c2C1)c1ccc(OC(F)(F)F)cc1,5.40000018605658
CHEMBL2069408,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3162.28,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3cccnc3)c2C1)c1ccc(OCC(F)(F)F)nc1,5.499999678657065
CHEMBL2069409,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3162.28,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3ccncc3)c2C1)c1ccc(OCC(F)(F)F)nc1,5.499999678657065
CHEMBL2069410,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3981.07,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cc1F,5.40000018605658
CHEMBL2069411,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3ccc(CO)nc3)c2C1)c1ccc(OCC(F)(F)F)nc1,5.200000237109354
CHEMBL2069412,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3ccnc(CO)c3)c2C1)c1ccc(OCC(F)(F)F)nc1,5.200000237109354
CHEMBL2069413,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7943.28,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3ccc(CO)nc3)c2C1)c1ccc(OCCOCC(F)(F)F)nc1,5.100000128334196
CHEMBL2069414,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,CC(O)c1ccc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCCOCC(F)(F)F)nc2)CO3)cn1,5.0
CHEMBL2069415,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,Cc1cc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCCOCC(F)(F)F)nc2)CO3)cnc1CO,5.300000202445418
CHEMBL2069420,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3981.07,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,O=C(N[C@@H]1COc2cccc(-c3cncnc3)c2C1)c1ccc(OCCC(F)(F)F)nc1,5.40000018605658
CHEMBL2069421,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cn1,5.200000237109354
CHEMBL2069422,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3981.07,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCCC(F)(F)F)nc2)CO3)cn1,5.40000018605658
CHEMBL2069423,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(COCC(F)(F)F)nc2)CO3)cn1,5.0
CHEMBL2069424,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,Cc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cn1,5.300000202445418
CHEMBL2069427,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12589.25,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,COc1cnc(-c2cccc3c2C[C@H](NC(=O)c2ccc(COCC(F)(F)F)nc2)CO3)cn1,4.900000142057633
CHEMBL2069428,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19952.62,nM,CHEMBL2072751,B,Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay,CHEMBL2069242,IC50,Cc1cnc(-c2cccc3c2C[C@H](NC(=O)c2ccc(COCC(F)(F)F)nc2)CO3)cn1,4.70000006855703
CHEMBL2147210,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12589.25,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2ccccc2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,4.900000142057633
CHEMBL2147211,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1cnc(-c2ccccc2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.200000237109354
CHEMBL2147212,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,O=C(NCCc1ccccc1-c1cnc(OC(F)F)cn1)c1ccc(OCCC(F)(F)F)nc1,5.200000237109354
CHEMBL2147213,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,O=C(NCCc1ccccc1-c1cccnc1)c1ccc(OCCC(F)(F)F)nc1,5.200000237109354
CHEMBL2147214,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,Cc1ncc(-c2ccccc2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.300000202445418
CHEMBL2147219,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,Cc1ncc(-c2ccccc2CCNC(=O)c2ccc(C(=O)NCCCC(F)(F)F)nc2)cn1,5.200000237109354
CHEMBL2147221,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2cccc(C)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.200000237109354
CHEMBL2147222,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3162.28,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2cccc(F)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.499999678657065
CHEMBL2147223,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5011.87,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2cccc(Cl)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.300000202445418
CHEMBL2147224,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6309.57,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2cccc(OC)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.200000237109354
CHEMBL2147225,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19952.62,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ccc(CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)c(-c2cnc(OC)nc2)c1,4.70000006855703
CHEMBL2147304,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7943.28,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2cccc(OC(F)F)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,5.100000128334196
CHEMBL2147305,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,794.33,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2c(C)ccc(F)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,6.0999990348465305
CHEMBL2147306,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2511.89,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2c(C)ccc(F)c2CCNC(=O)c2ccc(OCC(F)(F)F)nc2)cn1,5.59999938302362
CHEMBL2147307,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1000.0,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1cnc(-c2c(C)ccc(F)c2CCNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,6.0
CHEMBL2147308,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1584.89,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1cnc(-c2c(F)ccc(F)c2CCNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,5.800000874803203
CHEMBL2147309,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1584.89,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,Cc1cnc(-c2c(F)ccc(F)c2CCNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,5.800000874803203
CHEMBL2147303,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19952.62,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1ncc(-c2ccccc2C(F)(F)CNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,4.70000006855703
CHEMBL2147316,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,31622.78,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1cnc(-c2ccccc2C(F)(F)CNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,4.499999953328896
CHEMBL2147317,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL2149458,B,Inhibition of human Nav1.5,CHEMBL2146409,IC50,COc1cnc(-c2cccc(F)c2C(F)(F)CNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,5.0
CHEMBL698,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,530.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,6.275724130399211
CHEMBL629,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1600.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CN(C)CCC=C1c2ccccc2CCc2ccccc21,5.795880017344075
CHEMBL2164043,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(F)c(OC(F)(F)F)c1)C1c2ccccc2C(=O)N1CCc1ncc(F)cn1,4.769551078621726
CHEMBL2164041,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,940.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2cccc(O)c2C(=O)N1CCc1ccccn1,6.026872146400301
CHEMBL2164040,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8500.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,COc1cccc2c1C(=O)N(CCc1ccccn1)C2C(=O)NCc1ccc(OC(F)(F)F)cc1,5.070581074285707
CHEMBL2164039,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2cccc(F)c2C(=O)N1CCc1ccccn1,4.769551078621726
CHEMBL2164037,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,16000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,COc1cccc2c1C(C(=O)NCc1ccc(OC(F)(F)F)cc1)N(CCc1ccccn1)C2=O,4.795880017344075
CHEMBL2164369,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4700.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,Cc1cccc2c1C(C(=O)NCc1ccc(OC(F)(F)F)cc1)N(CCc1ccccn1)C2=O,5.327902142064282
CHEMBL2164368,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,810.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2c(F)cccc2C(=O)N1CCc1ccccn1,6.0915149811213505
CHEMBL2164367,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC1(C(=O)NCc2ccc(OC(F)(F)F)cc2)c2ccccc2C(=O)N1CCc1ccccn1,4.6020599913279625
CHEMBL2164367,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC1(C(=O)NCc2ccc(OC(F)(F)F)cc2)c2ccccc2C(=O)N1CCc1ccccn1,4.568636235841013
CHEMBL2164366,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ncc(F)cn1,4.721246399047171
CHEMBL2164365,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1cnccn1,4.920818753952375
CHEMBL2164363,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CC(F)(F)c1ccccn1,5.721246399047171
CHEMBL2164361,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC(C)(Cc1ccccn1)N1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1,4.886056647693163
CHEMBL2164360,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC(Cc1ccccn1)N1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1,5.3979400086720375
CHEMBL2164359,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4300.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1Cc1ccc(C(F)(F)F)cn1,5.366531544420413
CHEMBL2164358,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9700.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCOc1ccccn1,5.013228265733755
CHEMBL2164357,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7900.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCCc1ccccn1,5.102372908709558
CHEMBL2164356,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,Cc1cccc(CCN2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)n1,5.721246399047171
CHEMBL2164047,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1200.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccc(F)cn1,5.920818753952375
CHEMBL2164046,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6100.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccncc1,5.214670164989233
CHEMBL2164382,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2600.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1cccnc1,5.585026652029182
CHEMBL2164378,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCC(F)(F)F,4.721246399047171
CHEMBL2164377,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CC1CC(F)(F)C1,4.7447274948966935
CHEMBL2164376,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CC(F)(F)C1,4.920818753952375
CHEMBL2164375,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4400.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC(C)(C)OC(=O)N1CC(N2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)C1,5.356547323513812
CHEMBL2164374,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4500.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC(C)(C)OC(=O)N1CCC(N2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)CC1,5.346787486224656
CHEMBL2163357,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6100.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,N#C[C@H]1CC[C@H](N2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)CC1,5.214670164989233
CHEMBL2164373,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCC(F)(F)CC1,4.853871964321762
CHEMBL2164370,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2900.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCN1CCOCC1,5.537602002101044
CHEMBL2164397,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCC1CCOCC1,4.721246399047171
CHEMBL2164393,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3700.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,CC(NC(=O)C1c2ccccc2C(=O)N1CCc1ccccn1)c1ccc(OCC(F)(F)F)cc1,5.431798275933005
CHEMBL2164392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8900.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OCC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,5.050609993355087
CHEMBL2164391,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4400.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(CC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,5.356547323513812
CHEMBL2164390,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2800.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1cccc(OC(F)(F)F)c1)C1c2ccccc2C(=O)N1CCc1ccccn1,5.552841968657781
CHEMBL2164389,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,4.7447274948966935
CHEMBL2164389,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,730.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,6.136677139879544
CHEMBL2164389,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1200.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,5.920818753952375
CHEMBL2164387,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1600.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(C(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,5.795880017344075
CHEMBL2164385,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1cccc(Br)c1)C1c2ccccc2C(=O)N1CCc1ccccn1,4.920818753952375
CHEMBL2164384,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8700.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,O=C(NCc1ccc(Br)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,5.060480747381382
CHEMBL2164383,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1200.0,nM,CHEMBL2168490,B,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL2163233,IC50,Cc1ccc(NC(=O)C2c3ccccc3C(=O)N2CCc2ccccn2)cc1C,5.920818753952375
CHEMBL2069427,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL2328112,B,Inhibition of human voltage-gated Na channel 1.5 by cell based patch clamp technique,CHEMBL2321869,IC50,COc1cnc(-c2cccc3c2C[C@H](NC(=O)c2ccc(COCC(F)(F)F)nc2)CO3)cn1,4.886056647693163
CHEMBL2409401,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,28000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COCCN1CCN(c2cc3c(Nc4ccc(C)cc4F)c(C(N)=O)nnc3cc2OC)CC1,4.552841968657781
CHEMBL2409402,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCCN(CCO)CC1,4.568636235841013
CHEMBL2409407,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,26000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(CCO)CC1,4.585026652029182
CHEMBL2409410,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1C1CCN(CCO)CC1,4.6020599913279625
CHEMBL2409400,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,24000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCC(N(C)C)CC1,4.619788758288394
CHEMBL2409399,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1C[C@@H](C)N[C@@H](C)C1,4.853871964321762
CHEMBL481806,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1,4.853871964321762
CHEMBL521096,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C)CC1,4.920818753952375
CHEMBL2409398,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCCN(C)CC1,4.958607314841775
CHEMBL481008,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,CCOc1cc2ncc(C(N)=O)c(Nc3cccc(Cl)c3Cl)c2cc1N1CCN(C)CC1,5.045757490560675
CHEMBL2409409,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1C1CCN(C(C)C)CC1,5.154901959985743
CHEMBL1683036,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C)CC1,5.221848749616356
CHEMBL2409397,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4000.0,nM,CHEMBL2411830,B,Inhibition of human Nav1.5,CHEMBL2406904,IC50,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C(C)C)CC1,5.3979400086720375
CHEMBL2418811,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3300.0,nM,CHEMBL2422129,B,Inhibition of NaV1.5 channel (unknown origin) by patch express-based electrophysiology assay,CHEMBL2417435,IC50,Cc1sc(Nc2ccc(Cl)cc2F)nc1C(=O)N1CCC[C@H](C)[C@@H]1C,5.481486060122112
CHEMBL2418806,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,50000.0,nM,CHEMBL2422129,B,Inhibition of NaV1.5 channel (unknown origin) by patch express-based electrophysiology assay,CHEMBL2417435,IC50,Cc1ccc(Nc2nc(C(=O)N3CCCC(C)C3C)cs2)cc1,4.301029995663981
CHEMBL2443262,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,16500.0,nM,CHEMBL2445976,B,Inhibition of human Nav 1.5 tonic ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL2440083,IC50,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1,4.782516055786093
CHEMBL2443278,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20000.0,nM,CHEMBL2445976,B,Inhibition of human Nav 1.5 tonic ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL2440083,IC50,c1ccc([C@]2(CCNCc3cccs3)CCOC3(CCCC3)C2)nc1,4.698970004336019
CHEMBL2443262,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4700.0,nM,CHEMBL2445977,B,Inhibition of human Nav 1.5 phasic ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL2440083,IC50,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1,5.327902142064282
CHEMBL2443278,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9000.0,nM,CHEMBL2445977,B,Inhibition of human Nav 1.5 phasic ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL2440083,IC50,c1ccc([C@]2(CCNCc3cccs3)CCOC3(CCCC3)C2)nc1,5.045757490560675
CHEMBL3085879,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,21000.0,nM,CHEMBL3090651,B,Modulation of human Nav1.5 by automated patch clamp electrophysiology assay,CHEMBL3085695,IC50,Nc1nc2c(s1)C[C@@H](NC(=O)c1cc(Br)c[nH]1)CC2,4.6777807052660805
CHEMBL3085872,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,21000.0,nM,CHEMBL3090651,B,Modulation of human Nav1.5 by automated patch clamp electrophysiology assay,CHEMBL3085695,IC50,Nc1nc2c(s1)CC(CNC(=O)c1ccc[nH]1)CC2,4.6777807052660805
CHEMBL3085876,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20000.0,nM,CHEMBL3090651,B,Modulation of human Nav1.5 by automated patch clamp electrophysiology assay,CHEMBL3085695,IC50,CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)NCC1CCc2nc(N)sc2C1,4.698970004336019
CHEMBL3112596,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20000.0,nM,CHEMBL3119942,B,Modulation of human Nav1.5 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology,CHEMBL3112572,IC50,CNc1nc(-c2cccc(NC(=O)c3cc4ccccc4[nH]3)c2)c[nH]1.Cl,4.698970004336019
CHEMBL3113257,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20000.0,nM,CHEMBL3119942,B,Modulation of human Nav1.5 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology,CHEMBL3112572,IC50,CC(C)(C)OC(=O)n1cc(-c2ccc(NC(=O)[C@H]3CCCN3)cc2)nc1N,4.698970004336019
CHEMBL3113262,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL3119942,B,Modulation of human Nav1.5 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology,CHEMBL3112572,IC50,Nc1nc(-c2cccc(NC(=O)c3ccc[nH]3)c2)cn1C(=O)c1ccc[nH]1,4.568636235841013
CHEMBL3128194,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5600.0,nM,CHEMBL3128856,B,Inhibition of human NaV1.5,CHEMBL3124772,IC50,Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,5.251811972993799
CHEMBL3236329,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,36000.0,nM,CHEMBL3242069,B,Inhibition of human Nav1.5 assessed as tonic block by patch-clamp electrophysiology/cell based assay,CHEMBL3232919,IC50,O=C(NCc1noc(-c2c3ccccc3nn2CCn2ccnc2)n1)c1cccc(OC(F)(F)F)c1,4.443697499232713
CHEMBL3236329,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14800.0,nM,CHEMBL3242070,B,Inhibition of human Nav1.5 assessed as 10 Hz block by patch-clamp electrophysiology/cell based assay,CHEMBL3232919,IC50,O=C(NCc1noc(-c2c3ccccc3nn2CCn2ccnc2)n1)c1cccc(OC(F)(F)F)c1,4.8297382846050425
CHEMBL3236343,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,69000.0,nM,CHEMBL3242070,B,Inhibition of human Nav1.5 assessed as 10 Hz block by patch-clamp electrophysiology/cell based assay,CHEMBL3232919,IC50,O=C(NCc1noc(-c2nn(CCn3ccnc3)c3ccccc23)n1)c1ccccc1,4.161150909262744
CHEMBL3236329,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,920.0,nM,CHEMBL3242071,B,Inhibition of human Nav1.5 assessed as inactivated-state block by patch-clamp electrophysiology/cell based assay,CHEMBL3232919,IC50,O=C(NCc1noc(-c2c3ccccc3nn2CCn2ccnc2)n1)c1cccc(OC(F)(F)F)c1,6.036212172654444
CHEMBL3236343,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19000.0,nM,CHEMBL3242071,B,Inhibition of human Nav1.5 assessed as inactivated-state block by patch-clamp electrophysiology/cell based assay,CHEMBL3232919,IC50,O=C(NCc1noc(-c2nn(CCn3ccnc3)c3ccccc23)n1)c1ccccc1,4.721246399047171
CHEMBL3341980,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4750.0,nM,CHEMBL3368014,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells by IonWorks patch-clamp method,CHEMBL3351765,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1ncnc2cc(S(=O)(=O)Nc3ncns3)ccc12,5.323306390375134
CHEMBL3341984,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1200.0,nM,CHEMBL3368018,B,Inhibition of Nav1.5 (unknown origin) by PatchXpress method,CHEMBL3351765,IC50,CC(C)Oc1ncc(Oc2cc(F)c(C(=O)NS(=O)(=O)N3CCC3)cc2C2CC2)cc1Cl,5.920818753952375
CHEMBL3341985,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1070.0,nM,CHEMBL3368018,B,Inhibition of Nav1.5 (unknown origin) by PatchXpress method,CHEMBL3351765,IC50,CS(=O)(=O)NC(=O)c1cc(Cl)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,5.97061622231479
CHEMBL3314349,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10300.0,nM,CHEMBL3368359,B,Inhibition of human Nav1.5 expressed in CHO cells by electrophysiology assay,CHEMBL3352699,IC50,CN(C)Cc1ccc2c(c1)CCN(C(=O)c1cc3cc(Cl)ccc3n1C)C2,4.987162775294828
CHEMBL3325526,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5200.0,nM,CHEMBL3390670,B,Inhibition of human Nav1.5 expressed in HEK cells assessed as reduction in sodium current at -60 mV holding potential by PatchXpress platform based whole cell patch clamp electrophysiological assay,CHEMBL3352194,IC50,O=S(=O)(Nc1ncns1)c1cc(F)c(OC[C@H]2CNCC[C@@H]2c2ccc(Cl)cc2)cc1F,5.2839966563652006
CHEMBL3325532,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5900.0,nM,CHEMBL3390670,B,Inhibition of human Nav1.5 expressed in HEK cells assessed as reduction in sodium current at -60 mV holding potential by PatchXpress platform based whole cell patch clamp electrophysiological assay,CHEMBL3352194,IC50,O=S(=O)(Nc1ncns1)c1cc(F)c(OC[C@@H]2CCNC[C@H]2c2ccc(F)cc2)cc1F,5.229147988357855
CHEMBL3325534,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,24700.0,nM,CHEMBL3390670,B,Inhibition of human Nav1.5 expressed in HEK cells assessed as reduction in sodium current at -60 mV holding potential by PatchXpress platform based whole cell patch clamp electrophysiological assay,CHEMBL3352194,IC50,O=S(=O)(Nc1ncns1)c1cc(F)c(OC[C@@H]2CCCC[C@H]2c2ccc(Cl)cc2)cc1F,4.607303046740334
CHEMBL3325540,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2600.0,nM,CHEMBL3390670,B,Inhibition of human Nav1.5 expressed in HEK cells assessed as reduction in sodium current at -60 mV holding potential by PatchXpress platform based whole cell patch clamp electrophysiological assay,CHEMBL3352194,IC50,O=S(=O)(Nc1ncns1)c1cc(F)c(OC[C@@H]2CN(CC(F)(F)F)CC[C@H]2c2ccc(Cl)cc2)cc1F,5.585026652029182
CHEMBL3322777,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,572.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc(OC)c(N(C)C)c3)CC1)c1cccn1-2,6.242603971206975
CHEMBL3337583,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,181.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc(C(=O)N2CCC3(CC2)Nc2cc(OC(F)(F)F)ccc2-n2cccc23)cc1N(C)C,6.7423214251308154
CHEMBL3337584,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,340.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc(C(=O)N2CCC3(CC2)Nc2cc(OC(F)F)ccc2-n2cccc23)cc1N(C)C,6.468521082957745
CHEMBL3337585,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,217.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc(C(=O)N2CCC3(CC2)Nc2cc(C(F)(F)F)ccc2-n2cccc23)cc1N(C)C,6.66354026615147
CHEMBL3337586,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2216.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COCCOc1ccc2c(c1)NC1(CCN(C(=O)c3ccc(OC)c(N(C)C)c3)CC1)c1cccn1-2,5.654430243943608
CHEMBL3337587,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,358.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1cc2c(cc1F)-n1cccc1C1(CCN(C(=O)c3ccc(OC)c(N(C)C)c3)CC1)N2,6.446116973356125
CHEMBL3337589,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,519.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)N[C@@]1(CCN(C(=O)c3ccc(OC)c(N(C)C)c3)C[C@@H]1C)c1cccn1-2,6.284832642151542
CHEMBL3337590,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CN(C(=O)c3ccc4ncccc4c3)C1)c1cccn1-2,4.522878745280337
CHEMBL3337591,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3069.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCCN(C(=O)c3ccc(OC)c(N(C)C)c3)CC1)c1cccn1-2,5.513003111568177
CHEMBL3337592,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2450.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CC3CN(C(=O)c4ccc(OC)c(N(C)C)c4)CC3C1)c1cccn1-2,5.610833915635467
CHEMBL3337593,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCC(NC(=O)c3ccc(OC)c(N(C)C)c3)CC1)c1cccn1-2,4.522878745280337
CHEMBL3337588,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3261.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)N[C@]1(CCN(C(=O)c3ccc(OC)c(N(C)C)c3)[C@H](C)C1)c1cccn1-2,5.486649201194043
CHEMBL3337595,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,118.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc(OC)c(N4CCCC4)c3)CC1)c1cccn1-2,6.928117992693874
CHEMBL3337594,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1138.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc4c(c3)N(C)CCO4)CC1)c1cccn1-2,5.943857737940948
CHEMBL3337596,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1186.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,CCCCc1nc2cc(C(=O)N3CCC4(CC3)Nc3cc(OC)ccc3-n3cccc34)ccc2o1,5.925915310971757
CHEMBL3337597,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1034.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc4ncccc4c3)CC1)c1cccn1-2,5.985479461242076
CHEMBL3337598,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2938.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3cccc4ncccc34)CC1)c1cccn1-2,5.531948208545762
CHEMBL3337599,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,419.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc4ccccc4n3)CC1)c1cccn1-2,6.377785977033705
CHEMBL3337600,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1732.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc4cccnc4c3)CC1)c1cccn1-2,5.761452112318672
CHEMBL3337601,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1653.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc4c(ccn4C)c3)CC1)c1cccn1-2,5.781727146428553
CHEMBL3337602,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2811.0,nM,CHEMBL3387119,B,Inhibition of human Nav1.5 expressed in HEK293 cells after 60 mins by FLIPR assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc4c(cnn4C)c3)CC1)c1cccn1-2,5.551139154392559
CHEMBL3322777,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10485.0,nM,CHEMBL3387122,B,Inhibition of human Nav1.5 expressed in HEK293 cells by voltage clamp assay,CHEMBL3351799,IC50,COc1ccc2c(c1)NC1(CCN(C(=O)c3ccc(OC)c(N(C)C)c3)CC1)c1cccn1-2,4.979431565198637
CHEMBL3416893,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.568636235841013
CHEMBL3318132,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,90.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CSCC[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]3CSSC[C@H](NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)O)CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC3=O)C(=O)N2,7.045757490560675
CHEMBL4524054,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25000.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N3)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1)C(=O)O,4.6020599913279625
CHEMBL3417035,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8800.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.055517327849831
CHEMBL3416946,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4500.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.346787486224656
CHEMBL3416944,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,500.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,6.301029995663981
CHEMBL3416943,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4600.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.337242168318426
CHEMBL3416942,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3600.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc4cccc5ccccc45)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.443697499232712
CHEMBL3416937,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,400.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4cccc5ccccc45)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,6.3979400086720375
CHEMBL3416936,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.468521082957745
CHEMBL3416934,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3000.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.522878745280337
CHEMBL3416933,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2800.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CC4CCCCC4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.552841968657781
CHEMBL3416931,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N[C@H](C(=O)N[C@@H](Cc4ccccc4)C(N)=O)C(C)C)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC2=O,5.958607314841775
CHEMBL3416930,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2100.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccc(-c5ccccc5)cc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.6777807052660805
CHEMBL3416926,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3500.0,nM,CHEMBL3419343,B,Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay,CHEMBL3414527,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC4CCCCC4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.455931955649724
CHEMBL3589894,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9000.0,nM,CHEMBL3590902,B,Inhibition of human Nav1.5 expressed in HEK293 cells by IonWorks Quattro selectivity assay,CHEMBL3588833,IC50,CNC(=O)c1ccc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1,5.045757490560675
CHEMBL3589904,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,37000.0,nM,CHEMBL3590902,B,Inhibition of human Nav1.5 expressed in HEK293 cells by IonWorks Quattro selectivity assay,CHEMBL3588833,IC50,COc1ccc(Cl)c(-c2ccc(NC(=O)c3ccnn3C)nc2N)c1,4.431798275933005
CHEMBL2324355,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL3590902,B,Inhibition of human Nav1.5 expressed in HEK293 cells by IonWorks Quattro selectivity assay,CHEMBL3588833,IC50,Cc1nocc1C(=O)Nc1ccc(-c2ccccc2OC(F)(F)F)c(N)n1,4.920818753952375
CHEMBL3617065,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7200.0,nM,CHEMBL3618954,B,Inhibition of human NaV1.5 channel expressed in HEK293 cells by patch clamp electrophysiology assay,CHEMBL3616397,IC50,CNS(=O)(=O)NC(=O)c1cc(Cl)c(Oc2cnc(OCC(C)C)c(Cl)c2)cc1F,5.142667503568731
CHEMBL3617064,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,22000.0,nM,CHEMBL3618954,B,Inhibition of human NaV1.5 channel expressed in HEK293 cells by patch clamp electrophysiology assay,CHEMBL3616397,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(O[C@H]2C3CC4CC2C[C@](Cl)(C4)C3)cc1F,4.657577319177793
CHEMBL3617050,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,0.28,nM,CHEMBL3618799,B,Inhibition of NaV1.5 channel (unknown origin) expressed in Xenopus laevis oocytes by two-electrode oocyte voltage-clamp method,CHEMBL3616397,IC50,N=C1N[C@@]23[C@H]([C@H]4NC(=N)N2C[C@](OS(=O)(=O)O)(C[C@H]2[C@@H](CO)CON2C4=O)C3(O)O)N1COC(=O)NO,9.55284196865778
CHEMBL1200606,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7800.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,Cc1cccc(C)c1OCC(C)N.Cl,5.107905397309519
CHEMBL3634321,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1COc2c(cccc2N2CCN(CC(O)COc3ccccc3C(=O)c3ccccc3)CC2)N1,4.698970004336019
CHEMBL3634322,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1COc2c(cccc2C2CCN(CC(O)COc3ccccc3C(=O)c3ccccc3)CC2)N1,5.154901959985743
CHEMBL3634323,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1CCc2c(cccc2N2CCN(CC(O)COc3ccccc3C(=O)c3ccccc3)CC2)N1,4.769551078621726
CHEMBL3634324,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1CCc2c(cccc2C2CCN(CC(O)COc3ccccc3C(=O)c3ccccc3)CC2)N1,4.7447274948966935
CHEMBL3634326,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5200.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1ccccc1OCC(O)CN1CCC(N2C(=O)COc3ccccc32)CC1,5.2839966563652006
CHEMBL3634327,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1ccccc1OCC(O)CN1CCC(n2c(=O)oc3ccccc32)CC1,5.468521082957745
CHEMBL3634328,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1ccccc1OCC(O)CN1CCC(N2C(=O)Cc3ccccc32)CC1,4.481486060122113
CHEMBL3634329,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,24000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1ccccc1OCC(O)CN1CCC(N2Cc3ccccc3C2=O)CC1,4.619788758288394
CHEMBL3634330,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4900.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(NC1CCN(CC(O)COc2ccccc2C(=O)c2ccccc2)CC1)c1ccccc1,5.309803919971486
CHEMBL3634331,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1ccccc1OCC(O)CN1CCC(C(=O)Nc2ccccc2)CC1,5.721246399047171
CHEMBL3634332,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3700.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1cccc(OCC(O)CN2CCC(N3Cc4ccccc4C3=O)CC2)c1,5.431798275933005
CHEMBL3632641,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1200.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(c1ccccc1)c1ccc(OCC(O)CN2CCC(N3Cc4ccccc4C3=O)CC2)cc1,5.920818753952375
CHEMBL3634333,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,38000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1c2ccccc2CN1C1CCN(CC(O)COc2ccccc2)CC1,4.42021640338319
CHEMBL3634334,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,77000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,COc1ccccc1OCC(O)CN1CCC(N2Cc3ccccc3C2=O)CC1,4.113509274827518
CHEMBL3634335,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,COc1cccc(OCC(O)CN2CCC(N3Cc4ccccc4C3=O)CC2)c1,5.0
CHEMBL3634336,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,COc1ccc(OCC(O)CN2CCC(N3Cc4ccccc4C3=O)CC2)cc1,4.886056647693163
CHEMBL3634337,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7100.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1c2ccccc2CN1C1CCN(CC(O)COc2ccccc2C(F)(F)F)CC1,5.1487416512809245
CHEMBL3632691,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4400.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1c2ccccc2CN1C1CCN(CC(O)COc2cccc(C(F)(F)F)c2)CC1,5.356547323513812
CHEMBL3632692,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2800.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1c2ccccc2CN1C1CCN(CC(O)COc2ccc(C(F)(F)F)cc2)CC1,5.552841968657781
CHEMBL3632693,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5600.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,COc1cc(C(F)(F)F)ccc1OCC(O)CN1CCC(N2Cc3ccccc3C2=O)CC1,5.251811972993799
CHEMBL3632694,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C1c2ccccc2CN1C1CCN(CC(O)COCc2ccc(C(F)(F)F)cc2)CC1,5.522878745280337
CHEMBL3632695,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6100.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,COc1cc(C(F)(F)F)ccc1COCC(O)CN1CCC(N2Cc3ccccc3C2=O)CC1.O=C(O)/C=C/C(=O)O,5.214670164989233
CHEMBL3632696,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(NC1CCN(CC(O)COc2ccc(C(F)(F)F)cc2)CC1)c1ccccc1,5.958607314841775
CHEMBL3632697,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,O=C(Nc1ccccc1)C1CCN(CC(O)COc2ccc(C(F)(F)F)cc2)CC1,5.468521082957745
CHEMBL3632698,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,16000.0,nM,CHEMBL3636866,B,Inhibition of human NaV1.5 by IonWorks quattro automated electrophysiology assay,CHEMBL3632552,IC50,COc1cc(C(F)(F)F)ccc1COCC(O)CN1CCC(C(=O)Nc2ccccc2)CC1,4.795880017344075
CHEMBL3683250,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6680.0,nM,CHEMBL3707668,B,"Ion Works Quattro (IWQ) Assay: In Vitro Assays 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the Ion Works® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, CA). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation.",CHEMBL3638380,IC50,O=S(=O)(Nc1ncc(F)s1)N1CCc2c(cccc2-c2ccc(C(F)(F)F)cc2C2=CCNCC2)C1,5.175223537524454
CHEMBL3657882,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3760.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(OCC23CC4CC(C2)C(F)(F)C(C4)C3)cc1F,5.424812155072339
CHEMBL3657921,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7820.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(OC2CC3CC2C2CCCC32)cc1F,5.106793246940152
CHEMBL3662229,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,160.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(C2CC2)c(OCC2(C(F)(F)F)CCCCC2)cc1F,6.795880017344075
CHEMBL3662236,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,670.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCCCC2)cc1F,6.173925197299173
CHEMBL3657851,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,159.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.798602875679549
CHEMBL3658002,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,350.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC2(C(F)(F)F)CCCCC2)cc1F,6.455931955649724
CHEMBL3704417,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8550.0,nM,CHEMBL3707612,B,"In Vitro Assay: 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation.Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3638977,IC50,Cn1nccc1-c1cc(C(F)(F)F)ccc1-c1c[nH]c2nc(S(=O)(=O)Nc3ncns3)ccc12,5.068033885271827
CHEMBL3704422,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7630.0,nM,CHEMBL3707612,B,"In Vitro Assay: 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation.Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3638977,IC50,Cn1cc(-c2ccc(F)c(C#N)c2)c2ccc(S(=O)(=O)Nc3ncns3)cc21,5.117475462045119
CHEMBL3341985,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(Cl)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,5.721246399047171
CHEMBL3654182,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1070.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CC1(C)[C@H]2CC[C@H](COc3cc(F)c(C(=O)NS(C)(=O)=O)cc3Cl)[C@@H]1C2,5.97061622231479
CHEMBL3662238,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,40.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC2CCCCC2)cc1F,7.3979400086720375
CHEMBL3657834,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2580.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cnc(OCC23CC4CC(CC(C4)C2)C3)c(C2CC2)c1,5.58838029403677
CHEMBL3657848,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,653.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CC1(C)CCc2cc(OCc3cc(F)c(C(=O)NS(=O)(=O)N4CCC4)cc3Cl)ccc2O1,6.185086818724926
CHEMBL3657950,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5230.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCC(F)(F)CC2)cc1F,5.281498311132726
CHEMBL3657929,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,743.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(Cl)c(OCC2CC3C4CCC(C4)C3C2)cc1F,6.129011186239424
CHEMBL3657937,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,714.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC23CC4CC(C2)C(F)(F)C(C4)C3)cc1F,6.146301788223825
CHEMBL3662230,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,940.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC2CCC(F)(F)CC2)cc1F,6.026872146400301
CHEMBL3657972,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,130.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC2C3CC4CC(C3)CC2C4)cc1F,6.886056647693163
CHEMBL3657943,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,326.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CC(F)(F)C1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.486782399932061
CHEMBL3657840,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,101.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,COCCS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.995678626217357
CHEMBL3662081,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,90.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC2(C(F)(F)F)CCCC2)cc1F,7.045757490560675
CHEMBL3657952,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,22.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)NCCCO)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.657577319177793
CHEMBL3662226,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2540.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CN(C(c3ccccc3)c3ccccc3)C2)cc1F,5.5951662833800615
CHEMBL3657855,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,51.5,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.288192770958809
CHEMBL3658014,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,430.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(C2CC2)c(OCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)cc1F,6.366531544420413
CHEMBL3683247,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5630.0,nM,CHEMBL3707668,B,"Ion Works Quattro (IWQ) Assay: In Vitro Assays 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the Ion Works® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, CA). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation.",CHEMBL3638380,IC50,CC(C)(C)OC(=O)N1CC=C(c2cc(C(F)(F)F)ccc2-c2cccc3c2CCN(S(=O)(=O)Nc2ncns2)C3)CC1,5.249491605148654
CHEMBL3683211,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4080.0,nM,CHEMBL3707668,B,"Ion Works Quattro (IWQ) Assay: In Vitro Assays 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the Ion Works® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, CA). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation.",CHEMBL3638380,IC50,O=S(=O)(Nc1ncns1)N1CCc2c(cccc2-c2ccc(C(F)(F)F)cc2-c2cccnc2)C1,5.3893398369101195
CHEMBL3658000,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,950.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)cc1F,6.022276394711152
CHEMBL3657932,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,26.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.585026652029182
CHEMBL3657930,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,427.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(Cl)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.369572124974976
CHEMBL3657934,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,422.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CC(F)C1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.374687549038326
CHEMBL3662093,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,160.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC23CCCCC2C3)cc1F,6.795880017344075
CHEMBL3657943,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,326.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CC(F)(F)C1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.486782399932061
CHEMBL3657998,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,630.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(C2CC2)c(OCC2CCC(F)(F)CC2)cc1F,6.200659450546418
CHEMBL3657820,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,772.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.1123826996642645
CHEMBL3657838,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,60.6,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CC(O)C1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.217527375833714
CHEMBL3657852,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1950.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1ccc(OCC23CC4CC(CC(C4)C2)C3)c(Br)c1,5.709965388637482
CHEMBL3657979,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3500.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)cc1F,5.455931955649724
CHEMBL3657929,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,743.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1cc(Cl)c(OCC2CC3C4CCC(C4)C3C2)cc1F,6.129011186239424
CHEMBL3662095,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15300.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,COCCS(=O)(=O)NC(=O)c1cnc(OCC23CC4CC(CC(C4)C2)C3)c(C2CC2)c1,4.815308569182402
CHEMBL3662094,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7500.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cnc(OCC23CC4CC(CC(C4)C2)C3)c(C2CC2)c1,5.1249387366083
CHEMBL3617064,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,21600.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(O[C@H]2C3CC4CC2C[C@](Cl)(C4)C3)cc1F,4.665546248849069
CHEMBL3657931,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,110.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CC[C@H](O)C1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.958607314841775
CHEMBL3662090,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,130.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(C2CC2)c(OCC23CC4CC(C2)C(F)(F)C(C4)C3)cc1F,6.886056647693163
CHEMBL3657939,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,O=C(NS(=O)(=O)N1CCOCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.853871964321762
CHEMBL3657953,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,144.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,COC1CN(S(=O)(=O)NC(=O)c2cc(C3CC3)c(OCC34CC5CC(CC(C5)C3)C4)cc2F)C1,6.84163750790475
CHEMBL3657967,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,140.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,COCCS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCCCC2)cc1F,6.853871964321762
CHEMBL3657877,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,700.0,nM,CHEMBL3705543,B,"Electrophysiological Assay: Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and allows the determination of the time- and voltage-dependence of block which has been interpreted as differential binding to the resting, open, and inactivated states of the sodium channel (Hille, B., Journal of General Physiology (1977), 69: 497-515).The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney cells (HEK), permanently transfected with an expression vector containing the full-length cDNA coding for the desired human sodium channel alpha -subunit, grown in culture media containing 10% FBS, 1% PSG, and 0.5 mg/mL G418 at 37 C. with 5% CO2. HEK cells used for the electrophysiology (EP) recordings had a passage number of less than 40 for all studies and were used within three days from the time of plating.",CHEMBL3638545,IC50,CS(=O)(=O)NC(=O)c1ccc(OCC23CC4CC(CC(C4)C2)C3)c(C2CC2)c1,6.154901959985743
CHEMBL3683232,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7260.0,nM,CHEMBL3707668,B,"Ion Works Quattro (IWQ) Assay: In Vitro Assays 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the Ion Works® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, CA). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation.",CHEMBL3638380,IC50,Cn1nccc1-c1cc(C(F)(F)F)ccc1-c1cccc2c1CCN(S(=O)(=O)Nc1ncccn1)C2,5.139063379299906
CHEMBL1684585,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL3767767,B,Inhibition of human Nav1.2 channel expressed in Xenopus oocytes by two-intracellular microelectrode voltage clamp method,CHEMBL3763146,IC50,Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1,4.522878745280337
CHEMBL3416893,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.568636235841013
CHEMBL3416944,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3500.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.455931955649724
CHEMBL3797461,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4cc5ccccc5[nH]4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.468521082957745
CHEMBL3800184,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3600.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.443697499232712
CHEMBL3416937,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2300.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4cccc5ccccc45)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.638272163982407
CHEMBL3800504,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,900.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cccc4ccccc24)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,6.045757490560675
CHEMBL3798824,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3500.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2cccc4ccccc24)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.455931955649724
CHEMBL3800441,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CSCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N[C@H](C(=O)N[C@@H](Cc4ccccc4)C(N)=O)C(C)C)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC2=O,5.468521082957745
CHEMBL3799379,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,37900.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.421360790031928
CHEMBL3798460,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,22700.0,nM,CHEMBL3803507,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.6439741428068775
CHEMBL3799550,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4500.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.346787486224656
CHEMBL3417035,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8800.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.055517327849831
CHEMBL3800248,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10100.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.995678626217358
CHEMBL3798860,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15900.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.798602875679548
CHEMBL3800461,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3200.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.494850021680094
CHEMBL4299620,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2700.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c4ccccc24)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC3=O)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.568636235841012
CHEMBL3416937,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,400.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4cccc5ccccc45)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,6.3979400086720375
CHEMBL3798261,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CSCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N[C@H](C(=O)N[C@@H](Cc4ccccc4)C(N)=O)C(C)C)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](Cc1cccc4ccccc14)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC2=O,4.886056647693163
CHEMBL3800588,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7800.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.107905397309519
CHEMBL3798824,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1000.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2cccc4ccccc24)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,6.0
CHEMBL3798843,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1800.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2cccc4ccccc24)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.7447274948966935
CHEMBL3797934,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13100.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccn4)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,4.882728704344236
CHEMBL3798549,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5000.0,nM,CHEMBL3803510,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method,CHEMBL3797186,IC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O,5.301029995663981
CHEMBL3798363,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2800.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C1NCCN1CCOc1nn(-c2ccccc2F)c2ccc(F)cc12,5.552841968657781
CHEMBL3798493,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1000.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C(COc1nn(-c2ccccc2F)c2ccc(F)cc12)N1CCOCC1,6.0
CHEMBL698,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,650.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,6.187086643357144
CHEMBL3799617,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5100.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=c1[nH]ccn1CCOc1nn(-c2ccccc2F)c2ccc(F)cc12,5.292429823902063
CHEMBL3797315,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2000.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,Fc1ccc2c(c1)c(OCCn1ccnc1)nn2-c1ccccc1F,5.698970004336019
CHEMBL3800304,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C1NCCN1CCOc1nn(-c2ccc(F)cc2F)c2ccc(F)cc12,5.468521082957745
CHEMBL3798258,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5000.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,CC(C)(C)OC(=O)N1CCN(c2cccc3c2cnn3-c2ccccc2F)C1=O,5.301029995663981
CHEMBL3798393,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19000.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,NC(=O)CN1CCN(c2cccc3c2cnn3-c2ccccc2F)C1=O,4.721246399047171
CHEMBL3799790,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,23000.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C(CN1CCN(c2cccc3c2cnn3-c2ccccc2F)C1=O)N1CCC[C@H](F)C1,4.638272163982407
CHEMBL3799551,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15000.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,CC(C)CC(=O)CN1CCN(c2cccc3c2cnn3-c2ccccc2F)C1=O,4.823908740944319
CHEMBL3799838,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14200.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C1N(Cc2ncco2)CCN1c1cccc2c1cnn2-c1ccccc1F,4.847711655616943
CHEMBL3797498,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3100.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C1N(c2ccncc2)CCN1c1cccc2c1cnn2-c1ccccc1F,5.508638306165727
CHEMBL3798039,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4400.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C1CN(c2cccc3c2cnn3-c2ccccc2F)CCN1CC(=O)N1CC[C@H](F)C1,5.356547323513812
CHEMBL3800069,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2500.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,O=C1C2CN(Cc3ccccc3)CC2CN1c1cccc2c1cnn2-c1ccccc1F,5.6020599913279625
CHEMBL3799939,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,16400.0,nM,CHEMBL3804567,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell-patch clamp method,CHEMBL3797111,IC50,CC(C)(O)CC(=O)N1CC[C@H]2CN(c3cccc4c3cnn4-c3ccccc3F)C(=O)[C@H]21,4.785156151952302
CHEMBL3341983,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1380.0,nM,CHEMBL3806692,B,Inhibition of full length human Nav1.5 channel expressed in HEK cells co-expressing human sodium channel subunit beta1 at holding potential -60 mV by automated voltage clamp analysis,CHEMBL3804797,IC50,Nc1noc2ccc(-c3cc(Cl)ccc3Oc3cc(F)c(S(=O)(=O)Nc4ncns4)cc3F)cc12,5.860120913598763
CHEMBL3806065,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,230.0,nM,CHEMBL3806692,B,Inhibition of full length human Nav1.5 channel expressed in HEK cells co-expressing human sodium channel subunit beta1 at holding potential -60 mV by automated voltage clamp analysis,CHEMBL3804797,IC50,CNc1noc2ccc(-c3cc(Cl)ccc3Oc3cc(F)c(S(=O)(=O)Nc4ncns4)cc3F)cc12,6.638272163982407
CHEMBL3809595,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,333.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.47755576649368
CHEMBL3808645,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,211.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)c1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.675717544702307
CHEMBL3808631,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7915.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,Fc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,5.101549080801625
CHEMBL3808917,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,887.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.052076380168273
CHEMBL3809838,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,281.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)COc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.55129368009492
CHEMBL3809812,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2221.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,COc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,5.6534514414515264
CHEMBL3808867,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,182.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,CC(C)(C)c1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.739928612014925
CHEMBL3810248,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,59.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,C[Si](C)(C)c1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,7.229147988357855
CHEMBL3809777,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,397.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)c1nnc2ccc(-c3ccc(S(F)(F)(F)(F)F)cc3)cn12,6.401209493236885
CHEMBL3809360,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,123.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,Cc1cc(OC(F)(F)F)ccc1-c1ccc2nnc(C(F)(F)F)n2c1,6.910094888560602
CHEMBL3810234,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,166.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,Cc1cc(-c2ccc3nnc(C(F)(F)F)n3c2)ccc1OC(F)(F)F,6.779891911959945
CHEMBL3808737,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1647.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,COc1cc2nnc(C(F)(F)F)n2cc1-c1ccc(OC(F)(F)F)cc1,5.783306400830245
CHEMBL3809933,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7541.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,CN(C)c1nnc2ccc(-c3ccc(OC(F)(F)F)cc3)cn12,5.12257105921178
CHEMBL3810266,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8935.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3nncn3c2)cc1,5.048905443158337
CHEMBL3809528,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,351.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)c1nnc2ccc(-c3ccc(OC(F)(F)F)cc3)cn12,6.454692883534176
CHEMBL3809877,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,941.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3ncnn3c2)cc1,6.026410376572743
CHEMBL3810347,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,223.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3n2)cc1,6.651695136951839
CHEMBL3809404,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,102.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3cnc(C(F)(F)F)n3c2)cc1,6.991399828238082
CHEMBL3809853,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,353.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3ncc(C(F)(F)F)n3c2)cc1,6.452225294612178
CHEMBL3808489,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3345.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccc3nc(C(F)(F)F)cn3c2)cc1,5.475603877896158
CHEMBL3808625,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1512.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccn3nccc3n2)cc1,5.820448208834812
CHEMBL3808581,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5052.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,Cc1cnn2ccc(-c3ccc(OC(F)(F)F)cc3)nc12,5.2965366581167075
CHEMBL3810153,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,901.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccn3ncc(C(F)(F)F)c3n2)cc1,6.045275209020938
CHEMBL3809080,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,425.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccn3nccc3c2)cc1,6.371611069949688
CHEMBL3809904,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,417.0,nM,CHEMBL3811490,B,Inhibition of Nav 1.5 (unknown origin) assessed as reduction in late channel current,CHEMBL3808345,IC50,FC(F)(F)Oc1ccc(-c2ccn3ncc(C(F)(F)F)c3c2)cc1,6.379863945026242
CHEMBL3809595,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,333.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,FC(F)(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.47755576649368
CHEMBL2147142,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,134000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1noc(Cn2nc3ccc(-c4ccc(Oc5ccc(Cl)cc5)cc4)cn3c2=O)n1,3.8728952016351927
CHEMBL3809097,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,740000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,O=c1n(Cc2nnc(C3CC3)o2)nc2ccc(-c3ccc(Oc4ccc(F)cc4)cc3)cn12,3.1307682802690238
CHEMBL3810356,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,981000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,O=c1n(Cc2noc(CO)n2)nc2ccc(-c3ccc(Oc4ccc(F)cc4)cc3)cn12,3.008330992620052
CHEMBL3809744,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,541000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1nc(Cn2nc3ccc(-c4ccc(Oc5ccc(F)cc5)cc4)cn3c2=O)no1,3.2668027348934308
CHEMBL3810384,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1903000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,O=c1[nH]nc2ccc(-c3ccc(Oc4ccc(F)cc4)cc3)cn12,2.7205612117129796
CHEMBL2147143,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,215000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1noc(Cn2nc3ccc(-c4ccc(Oc5ccc(F)cc5)cc4)cn3c2=O)n1,3.667561540084395
CHEMBL3810147,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,O=c1n(Cc2nc(C3CC3)co2)nc2ccc(-c3ccc(OC(F)(F)F)cc3)cn12,5.522878745280337
CHEMBL3810355,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2500.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1cnc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)o1,5.6020599913279625
CHEMBL3810138,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3500.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,O=c1n(Cc2nc(-c3c(Cl)cccc3Cl)no2)nc2ccc(-c3ccc(OC(F)(F)F)cc3)cn12,5.455931955649724
CHEMBL3809561,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4000.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,CCc1noc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)n1,5.3979400086720375
CHEMBL3808641,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2500.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1coc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)n1,5.6020599913279625
CHEMBL3808635,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3300.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1nc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)no1,5.481486060122112
CHEMBL3809055,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,O=c1[nH]nc2ccc(-c3ccc(OC(F)(F)F)cc3)cn12,5.721246399047171
CHEMBL3809641,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL3813329,B,Inhibition of 0.1 Hz stimulated human Nav1.5alpha expressed in HEK293 cells assessed as inhibition of late sodium current with 3 compound additions for 7 to 8 mins at holding potential -120 mV in presence of late sodium current activator tefluthrin/ATX2 measured immediately after third compound addition by PatchXpress method,CHEMBL3808373,IC50,Cc1noc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)n1,5.721246399047171
CHEMBL3809595,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,250.0,nM,CHEMBL3813472,B,Inhibition of Nav1.5 (unknown origin) assessed as inhibition of late sodium current by manual patch clamp method,CHEMBL3808373,IC50,FC(F)(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,6.6020599913279625
CHEMBL3809641,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1330.0,nM,CHEMBL3813472,B,Inhibition of Nav1.5 (unknown origin) assessed as inhibition of late sodium current by manual patch clamp method,CHEMBL3808373,IC50,Cc1noc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)n1,5.876148359032914
CHEMBL3905835,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,21000.0,nM,CHEMBL3865492,B,Inhibition of Nav1.5 (unknown origin),CHEMBL3864182,IC50,Cc1nccn1-c1ccc(-c2cn(CC(=O)Nc3cccc(Cl)c3Cl)nn2)cc1,4.6777807052660805
CHEMBL3968947,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17430.0,nM,CHEMBL3868265,B,Inhibition of Nav1.5 (unknown origin),CHEMBL3867472,IC50,O=C(O)CCCOc1ccc(-c2cc(OC(F)(F)F)ccc2Cl)cc1,4.758702612890007
CHEMBL3909872,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9134.0,nM,CHEMBL3868265,B,Inhibition of Nav1.5 (unknown origin),CHEMBL3867472,IC50,Cc1cc(-c2cc(OC(F)(F)F)ccc2Cl)cc(C)c1OCCCC(=O)O,5.039338992729018
CHEMBL3980898,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL3872165,B,Inhibition of Nav1.5 (unknown origin),CHEMBL3871307,IC50,CO[C@H]1C[C@H](Oc2cc(F)c(F)c(-c3ccc4c(c3)CC[C@H](CCC(=O)O)O4)n2)C1,4.568636235841013
CHEMBL3928500,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,37200.0,nM,CHEMBL3879991,B,Inhibition of human H1 Na+ channel expressed in HEK cells by patch clamp method,CHEMBL3879887,IC50,COc1ccc(CCO[C@H]2CCCC[C@@H]2N2CC[C@H](O)C2)cc1OC.Cl,4.429457060118103
CHEMBL3931230,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25400.0,nM,CHEMBL3879991,B,Inhibition of human H1 Na+ channel expressed in HEK cells by patch clamp method,CHEMBL3879887,IC50,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@H](O)C2)cc1OC.Cl,4.5951662833800615
CHEMBL3914098,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30300.0,nM,CHEMBL3879991,B,Inhibition of human H1 Na+ channel expressed in HEK cells by patch clamp method,CHEMBL3879887,IC50,COc1ccc(CCOC2CCCCC2N2CCC(O)C2)cc1OC.Cl,4.518557371497695
CHEMBL3916855,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,36400.0,nM,CHEMBL3879991,B,Inhibition of human H1 Na+ channel expressed in HEK cells by patch clamp method,CHEMBL3879887,IC50,COc1ccc(CCO[C@H]2CCCC[C@@H]2N2CC[C@@H](O)C2)cc1OC.Cl,4.438898616350944
CHEMBL2107383,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18600.0,nM,CHEMBL3879991,B,Inhibition of human H1 Na+ channel expressed in HEK cells by patch clamp method,CHEMBL3879887,IC50,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC.Cl,4.730487055782084
CHEMBL3707392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,600.0,nM,CHEMBL3883129,B,Inhibition of human NaV1.5 expressed in HEK293 cells assessed as blocking of tefluthrin-induced late sodium currents using -20 mV voltage steps at holding potential of -120 mV by whole cell patch clamp Qpatch method,CHEMBL3882737,IC50,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,6.221848749616356
CHEMBL1404,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6700.0,nM,CHEMBL3883129,B,Inhibition of human NaV1.5 expressed in HEK293 cells assessed as blocking of tefluthrin-induced late sodium currents using -20 mV voltage steps at holding potential of -120 mV by whole cell patch clamp Qpatch method,CHEMBL3882737,IC50,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,5.173925197299173
CHEMBL3677849,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,Cn1nccc1-c1cc(C(F)(F)F)ccc1-c1cccc2cc(S(=O)(=O)Nc3ncns3)ccc12,7.522878745280337
CHEMBL3677851,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,24200.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(F)cc3Br)cccc2c1,4.616184634019569
CHEMBL3677852,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10900.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(OC(F)(F)F)cc3Cl)cccc2c1,4.962573502059376
CHEMBL3677853,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,23800.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(F)cc3Cl)cccc2c1,4.623423042943488
CHEMBL3677856,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,21300.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccccc3Cl)cccc2c1,4.671620396561262
CHEMBL3677857,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,23800.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccccc3)cccc2c1,4.623423042943488
CHEMBL3677858,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6680.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,CCOc1cc(C(F)(F)F)ccc1-c1cccc2cc(S(=O)(=O)Nc3ncns3)ccc12,5.175223537524454
CHEMBL3682622,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5070.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,Cc1cc(C(F)(F)F)ccc1-c1cccc2cc(S(=O)(=O)Nc3ncns3)ccc12,5.2949920406666635
CHEMBL3682623,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11600.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(C(F)(F)F)ccc1-c1cccc2cc(S(=O)(=O)Nc3ncns3)ccc12,4.935542010773082
CHEMBL3682626,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1290.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,CC1(c2ccccc2)CN(c2cccc3cc(S(=O)(=O)Nc4ncns4)ccc23)CCO1,5.889410289700751
CHEMBL3682657,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5820.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,Cn1nccc1-c1cc(C(F)(F)F)ccc1-c1cccc2cc(S(=O)(=O)Nc3nccs3)ccc12,5.235077015350111
CHEMBL3682641,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19900.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(Cl)ccc1-c1cccc2cc(S(=O)(=O)Nc3ncns3)ccc12,4.701146923590294
CHEMBL3682644,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9580.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,Cc1cc(Cl)ccc1-c1cccc2cc(S(=O)(=O)Nc3ncns3)ccc12,5.018634490921455
CHEMBL3682645,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5960.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(Cl)cc3)cccc2c1,5.2247537402597635
CHEMBL3682646,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9990.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(Cl)cc3F)cccc2c1,5.000434511774017
CHEMBL3682647,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15100.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(C(F)(F)F)cc3F)cccc2c1,4.82102305270683
CHEMBL3682648,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14400.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(C(F)(F)F)cc3)cccc2c1,4.841637507904751
CHEMBL3682649,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,490.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(C(F)(F)F)cc3O)cccc2c1,6.309803919971486
CHEMBL3682650,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7770.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(Cl)cc3C(F)(F)F)cccc2c1,5.1095789811990855
CHEMBL3682816,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20400.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(C(F)(F)F)ccc1-c1ncc(O)c2cc(S(=O)(=O)Nc3nccs3)ccc12,4.690369832574102
CHEMBL3687547,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7440.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(C(F)F)c(Cl)cc1-c1ncnc2cc(S(=O)(=O)Nc3nccs3)ccc12,5.128427064454121
CHEMBL3687553,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12300.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(C(F)(F)F)ccc1-c1ccnc2cc(S(=O)(=O)Nc3nccs3)ccc12,4.910094888560602
CHEMBL3687594,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2790.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(C(F)(F)F)ccc1-c1ccnc2cc(S(=O)(=O)Nc3nccs3)c(F)cc12,5.554395796726403
CHEMBL3687601,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2500.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(C(F)(F)F)ccc1-c1ccnc2cc(S(=O)(=O)Nc3nccs3)c(C)cc12,5.6020599913279625
CHEMBL3687605,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20700.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1nccc2cc(S(=O)(=O)Nc3nncs3)ccc12,4.684029654543083
CHEMBL3687606,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,20300.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1nccc2cc(S(=O)(=O)Nc3ccncn3)ccc12,4.692503962086787
CHEMBL3687624,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,26600.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(-c2cccc(C(F)(F)F)c2)ccc1-c1nccc2cc(S(=O)(=O)Nc3ccncn3)ccc12,4.575118363368933
CHEMBL3687730,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19100.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(-c2cc(C)cc(Cl)c2)ccc1-c1nccc2cc(S(=O)(=O)Nc3ccncn3)ccc12,4.718966632752273
CHEMBL3341980,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4750.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1ncnc2cc(S(=O)(=O)Nc3ncns3)ccc12,5.323306390375134
CHEMBL3687747,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6590.0,nM,CHEMBL3705623,B,"In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of −50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed to −120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",CHEMBL3638921,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1ncnc2cc(S(=O)(=O)Nc3ccncn3)ccc12,5.18111458540599
CHEMBL3979043,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,496.0,nM,CHEMBL3888195,B,"Nav1.5 In Vitro PX Assay: 293 cells stably transfected with Nav 1.5 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system according the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Cells were held at a holding potential of -50 mV to inactivate sodium channels. To elicit sodium currents the voltage was changed -120 mV to recover a portion of the channels, followed by delivery of test pulses of 20 msec duration to 0 mV, at 0.1 Hz. A single concentration of test compound was applied to cells for a duration of 5 minutes.",CHEMBL3886193,IC50,COc1cc(-c2ccc(F)c(C)c2)c(F)cc1-n1c(=O)ccc2cc(S(=O)(=O)Nc3ccon3)c(F)cc21,6.304518323509802
CHEMBL3919513,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1870.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cn1nccc1-c1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3ncns3)ccc21,5.7281583934635005
CHEMBL3902709,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,944.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1-c1cn[nH]c1,6.025028005701931
CHEMBL3974650,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4030.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1Cl,5.39469495385889
CHEMBL3946087,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2290.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CC(C)(C)OC(=O)N1CC=C(c2cc(C(F)(F)F)ccc2N2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)CC1,5.6401645176601125
CHEMBL3922400,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,349.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCNCC1,6.45717457304082
CHEMBL3895680,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8250.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CN(C)CCn1ccc(NS(=O)(=O)c2ccc3c(c2)OCCN3c2ccc(C(F)(F)F)cc2Cl)n1,5.0835460514500745
CHEMBL3943111,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1330.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1-c1cccnc1,5.876148359032914
CHEMBL3937730,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5410.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1-c1cncnc1,5.266802734893431
CHEMBL3928707,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,214.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCOCC1,6.669586226650809
CHEMBL3952945,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,306.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1-c1ccncc1,6.514278573518419
CHEMBL3959065,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,634.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Nc1cc(-c2cc(C(F)(F)F)ccc2N2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)ccn1,6.1979107421182675
CHEMBL3954510,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1460.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3ncns3)ccc21,5.835647144215563
CHEMBL3930401,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4770.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ccncn1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1Cl,5.3214816209598865
CHEMBL3929582,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,254.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCNCC1,6.5951662833800615
CHEMBL3955295,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4930.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1cccc(Cl)c1,5.30715308072277
CHEMBL3960584,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1850.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1Br,5.732828271596986
CHEMBL3928011,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3590.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CN1CC=C(c2cc(C(F)(F)F)ccc2N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)CC1,5.444905551421681
CHEMBL3934179,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1200.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ccncn1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCNCC1,5.920818753952375
CHEMBL3911712,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7930.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ccncn1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1Br,5.100726812682396
CHEMBL3906169,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1150.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.939302159646388
CHEMBL3900428,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,957.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CN1CCN(c2cc(C(F)(F)F)ccc2N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)CC1,6.019088062223156
CHEMBL3909534,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,554.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1-c1ccncc1,6.2564902352715706
CHEMBL3948444,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,731.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1-c1cncnc1,6.13608262304214
CHEMBL3909713,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4790.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(Cl)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.319664486585436
CHEMBL3974790,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6700.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccccc1N1CCOc2cc(S(=O)(=O)Nc3ncns3)ccc21,5.173925197299173
CHEMBL3945380,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6300.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.200659450546418
CHEMBL3982796,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5570.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccccc1N1CCNCC1,5.2541448048262716
CHEMBL3927450,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2670.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1cscn1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCNCC1,5.573488738635424
CHEMBL3899549,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5280.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,[N-]=[N+]=Nc1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c(C2=CCNCC2)c1,5.277366077466188
CHEMBL3944914,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5330.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1ccc(Cl)c(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.273272790973428
CHEMBL3902690,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4830.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1cccc2ccncc12,5.316052869248487
CHEMBL3985774,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4440.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc2nccnc2c1,5.35261702988538
CHEMBL3969101,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6080.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(Cl)c(Cl)c1,5.216096420727265
CHEMBL3911479,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7370.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.132532512140949
CHEMBL3939449,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6030.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)cc1,5.219682687859849
CHEMBL3928626,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5640.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1ccc(F)c(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.248720896016658
CHEMBL3943018,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3810.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(F)c(F)c1,5.41907502432438
CHEMBL3969238,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2260.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1ncccn1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCNCC1,5.645891560852599
CHEMBL3928121,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1140.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3ccncn3)ccc21,5.943095148663527
CHEMBL3913715,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1840.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CC1CN(c2ccc(C(F)(F)F)cc2C#N)c2ccc(S(=O)(=O)Nc3nccs3)cc2O1,5.735182176990463
CHEMBL3904727,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,724.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,C[C@H]1CN(c2ccc(C(F)(F)F)cc2C#N)c2ccc(S(=O)(=O)Nc3nccs3)cc2O1,6.140261433802853
CHEMBL4109289,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6670.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,C[C@@H]1CN(c2ccc(C(F)(F)F)cc2C#N)c2ccc(S(=O)(=O)Nc3nccs3)cc2O1,5.175874166083451
CHEMBL3929191,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1400.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CC1COc2cc(S(=O)(=O)Nc3nccs3)ccc2N1c1ccc(C(F)(F)F)cc1C#N,5.853871964321762
CHEMBL4115193,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,851.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,C[C@@H]1COc2cc(S(=O)(=O)Nc3nccs3)ccc2N1c1ccc(C(F)(F)F)cc1C#N,6.070070439915412
CHEMBL3910936,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8500.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CC[C@H]1CN(c2ccc(C(F)(F)F)cc2C#N)c2ccc(S(=O)(=O)Nc3nccs3)cc2O1,5.070581074285707
CHEMBL3919882,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9590.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1cc(Cl)cnc1N1CC(C)Oc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.018181392829336
CHEMBL3890100,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3030.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1ncc(Cl)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.518557371497695
CHEMBL3902642,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3370.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(OCC(F)(F)F)cc1,5.4723700991286615
CHEMBL3927096,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5060.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1ccc(C(F)(F)F)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.2958494831602
CHEMBL3911657,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7730.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)cc1C#N,5.111820506081675
CHEMBL3939634,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7360.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)ccc1C#N,5.133122185662501
CHEMBL3912845,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7030.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)nc1,5.153044674980176
CHEMBL3935306,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5810.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(OC(F)(F)C(F)F)cc1,5.235823867609669
CHEMBL3907373,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2330.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(C#N)cc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.632644078973981
CHEMBL3925263,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6550.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(Cl)c(C(F)(F)F)c1,5.183758700008217
CHEMBL3949406,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3690.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccc(OC(F)(F)F)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.432973633840939
CHEMBL3929996,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6200.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1cncc(Cl)c1,5.207608310501746
CHEMBL3951692,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3830.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CCOc1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)cn1,5.416801226031377
CHEMBL3981707,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7040.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1ccc(OC)c(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.152427340857888
CHEMBL3921636,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6600.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(OC(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.180456064458131
CHEMBL3986882,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2500.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(-n2cccn2)cc1,5.6020599913279625
CHEMBL3908279,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7380.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1ncc(C(F)(F)F)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.131943638176958
CHEMBL3978706,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5220.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(OC(F)F)cnc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.282329496997738
CHEMBL3922625,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5580.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1cc(F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.253365801062421
CHEMBL3952857,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9420.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3cscn3)ccc21,5.025949097207123
CHEMBL3943628,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3930.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)ccc1Cl,5.405607449624574
CHEMBL3942240,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3490.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)cc(C)c1N(C)C,5.45717457304082
CHEMBL3957373,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3140.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)cc1Cl,5.503070351926786
CHEMBL3922776,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6440.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1cccc(Cl)c1Cl,5.1911141326401875
CHEMBL3983609,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2010.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#CCc1cccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.696803942579511
CHEMBL3944898,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5080.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)ccc1F,5.29413628771608
CHEMBL3934299,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5600.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1ccc(Cl)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.251811972993799
CHEMBL3906799,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5640.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccccc1OC(F)F,5.248720896016658
CHEMBL3978865,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6940.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1cc(Cl)ccc1Cl,5.158640529545146
CHEMBL3983724,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1990.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.701146923590294
CHEMBL3914297,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3170.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccc(C(F)(F)F)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.498940737782249
CHEMBL3948619,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7620.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1cccc(OC(F)(F)F)c1,5.118045028660399
CHEMBL3977812,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7720.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1cc(Cl)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.112382699664264
CHEMBL3896891,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3620.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccc(F)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.441291429466834
CHEMBL3933849,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7590.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1ccc(C#N)c(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.11975822410452
CHEMBL3911405,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1610.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1ccc(Cl)cc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.79317412396815
CHEMBL3948159,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1560.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(Cl)cc1OC(F)F,5.806875401645538
CHEMBL3923857,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3590.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1ccc(C#N)c(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c1,5.444905551421681
CHEMBL3960275,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5700.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,Cc1cc(Cl)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.2441251443275085
CHEMBL3926642,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1880.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(-c2ccccc2F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.72584215073632
CHEMBL3889675,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1220.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(-c2ccc(F)cc2)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.913640169325252
CHEMBL3917677,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,854.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(-c2cccc(F)c2)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,6.068542129310995
CHEMBL3916594,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4830.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1cc(-c2cccc(F)c2)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.316052869248487
CHEMBL3941069,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,686.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CC(C)c1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c(C#N)c1,6.163675884293248
CHEMBL3904074,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1090.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,CCc1ccc(N2CCOc3cc(S(=O)(=O)Nc4nccs4)ccc32)c(C#N)c1,5.962573502059376
CHEMBL3932071,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,637.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C(O)CO,6.195860567664649
CHEMBL3893102,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1140.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1CO,5.943095148663527
CHEMBL3944229,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3110.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1CC(O)CO,5.507239610973162
CHEMBL3894090,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,896.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C[C@H](O)CO,6.047691990337874
CHEMBL4109740,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,497.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C[C@@H](O)CO,6.303643611266668
CHEMBL3949355,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6110.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(Cl)cc1CC(O)CO,5.213958789757446
CHEMBL3946486,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,471.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,O=S(=O)(Nc1nccs1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1CCO,6.326979092871104
CHEMBL3907025,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,736.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)c(Cl)cc21,6.133122185662501
CHEMBL3950353,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,203.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)c(F)cc21,6.692503962086787
CHEMBL3919149,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5730.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2c1ccc(S(=O)(=O)Nc1nccs1)c2F,5.24184537803261
CHEMBL3920827,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1310.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,COc1cc(C#N)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)c(F)cc21,5.882728704344236
CHEMBL3948638,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,385.0,nM,CHEMBL3888490,B,"In Vitro Assay: HEK 293 cells stably transfected with either Nav 1.7 or with Nav 1.5 were recorded in population patch-clamp mode with the IonWorks® Quattro automated electrophysiology system in accordance with the manufacturer's specifications (Molecular Devices, LLC, Sunnyvale, Calif.). Sodium channel currents were measured in response to a train of depolarizations that induced successively greater inactivation. Cells were held at −110 mV for three seconds (Nav 1.7) or half a second (Nav 1.5) from a holding voltage of −15 mV, then put through a series of 26 pulses of 150 msec duration to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 minutes while a single concentration of test compound was added. Cells were then reclamped and put through the same voltage protocol. Current at the end of the 26th pulse to −20 mV was subtracted from the peak current evoked by the 26th pulse to −20 mV to correct for leak current.",CHEMBL3886728,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)cc(F)c21,6.414539270491499
CHEMBL4084542,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,40000.0,nM,CHEMBL3997717,B,Inhibition of Nav1.5 (unknown origin) by ionworks quattro electrophysiology assay,CHEMBL3994677,IC50,C[C@H](NC(=O)c1c(CN2CCC(N3CCCCC3)CC2)c(-c2cccc(C(F)(F)F)c2)nc2ccccc12)c1ccccc1,4.3979400086720375
CHEMBL4060154,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4900.0,nM,CHEMBL4009751,B,Inhibition of recombinant human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current at -50 mV holding potential measured after 600 secs by IonWorks Barracuda patch-clamp assay,CHEMBL4007444,IC50,N[C@H]1CC[C@@H](CCNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,5.309803919971486
CHEMBL4076627,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2600.0,nM,CHEMBL4009751,B,Inhibition of recombinant human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current at -50 mV holding potential measured after 600 secs by IonWorks Barracuda patch-clamp assay,CHEMBL4007444,IC50,N[C@H]1CC[C@@H](CNc2cc(F)c(S(=O)(=O)Nc3ncns3)cc2Cl)CC1,5.585026652029182
CHEMBL4078268,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL4009751,B,Inhibition of recombinant human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current at -50 mV holding potential measured after 600 secs by IonWorks Barracuda patch-clamp assay,CHEMBL4007444,IC50,N[C@H]1CC[C@@H](CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,5.721246399047171
CHEMBL4092078,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5100.0,nM,CHEMBL4009751,B,Inhibition of recombinant human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current at -50 mV holding potential measured after 600 secs by IonWorks Barracuda patch-clamp assay,CHEMBL4007444,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2(CN3CCCC3)CC2)cc1F,5.292429823902063
CHEMBL4060568,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL4012201,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current by ionworks quattro electrophysiology assay,CHEMBL4011598,IC50,COc1cc(-c2cccc(C(F)(F)F)c2)c(F)cc1-c1nccc2cc(S(=O)(=O)Nc3ccon3)ccc12,4.920818753952375
CHEMBL4068143,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,820.0,nM,CHEMBL4012201,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current by ionworks quattro electrophysiology assay,CHEMBL4011598,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1[nH]c(=O)cc2cc(S(=O)(=O)Nc3ccon3)ccc12,6.086186147616283
CHEMBL4090259,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,140.0,nM,CHEMBL4012201,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current by ionworks quattro electrophysiology assay,CHEMBL4011598,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1c(N)nnc2cc(S(=O)(=O)Nc3ccon3)ccc12,6.853871964321762
CHEMBL3687604,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1500.0,nM,CHEMBL4012201,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current by ionworks quattro electrophysiology assay,CHEMBL4011598,IC50,COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1nccc2cc(S(=O)(=O)Nc3ncns3)ccc12,5.823908740944319
CHEMBL4062193,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18200.0,nM,CHEMBL4036826,B,Inhibition of Nav1.5 (unknown origin),CHEMBL4033760,IC50,Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F,4.739928612014925
CHEMBL4101680,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17300.0,nM,CHEMBL4036826,B,Inhibition of Nav1.5 (unknown origin),CHEMBL4033760,IC50,N#Cc1ccc(-c2n[nH]c3cc(OC(F)(F)F)ccc23)cc1,4.761953896871205
CHEMBL4093377,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8520.0,nM,CHEMBL4036826,B,Inhibition of Nav1.5 (unknown origin),CHEMBL4033760,IC50,FC(F)(F)c1ccc2c(Nc3ccc(Cl)nc3)n[nH]c2c1,5.0695604052333
CHEMBL4061793,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2.2,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F,8.657577319177793
CHEMBL4104727,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,108.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@]23CCO[C@H]2OCC3)cc1F,6.96657624451305
CHEMBL4080500,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3400.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,C[C@]12OCC[C@@]1(CNc1cc(F)c(S(=O)(=O)Nc3nccs3)cc1Cl)CCO2,5.468521082957745
CHEMBL4071860,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,614.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@@]23CCCO[C@@H]2OCC3)cc1F,6.211831628858832
CHEMBL4071736,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,169.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@]23CCC[C@@]2(O)CCC3)cc1F,6.772113295386326
CHEMBL4089301,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,916.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CC4CC(C2)C(O)C(C4)C3)cc1F,6.03810452633215
CHEMBL4061129,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,260.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CC4CC(CC(O)(C4)C2)C3)cc1F,6.585026652029182
CHEMBL4097000,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1400.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC2CCOC2)cc1F,5.853871964321762
CHEMBL4069801,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,931.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC2CC3CCC2O3)cc1F,6.031050319018657
CHEMBL4101414,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,188.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCOC2)cc1F,6.7258421507363195
CHEMBL4076229,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,221.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCOC2)cc1F,6.655607726314889
CHEMBL4073353,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,133.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCCC2CCOC2)cc1F,6.876148359032914
CHEMBL4100208,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,189.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCCO2)cc1F,6.723538195826755
CHEMBL4083744,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,242.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2OCCO2)cc1F,6.616184634019569
CHEMBL4062009,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,336.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC2CCOCC2)cc1F,6.4736607226101555
CHEMBL4102647,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,127.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCOCC2)cc1F,6.896196279044043
CHEMBL4084713,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,706.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CC1CC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC(C)O1,6.151195298948196
CHEMBL4064762,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,120.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCOCC2)cc1F,6.920818753952375
CHEMBL4092463,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,237.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCCCO2)cc1F,6.625251653989896
CHEMBL4087220,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,74.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2COCCO2)cc1F,7.130768280269024
CHEMBL4065798,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,874.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCCCO2)cc1F,6.058488567365597
CHEMBL4099769,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,796.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC2CCCOC2)cc1F,6.099086932262331
CHEMBL4072883,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,76.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCCOC2)cc1F,7.119186407719209
CHEMBL4092025,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,328.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@@H]2CCCOC2)cc1F,6.484126156288321
CHEMBL4064295,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,156.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CC(C)(C)[C@H]1OCCC[C@@H]1CNc1cc(F)c(S(=O)(=O)Nc2nccs2)cc1Cl,6.806875401645538
CHEMBL4084268,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,415.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CC(C)(C)[C@@H]1OCCC[C@@H]1CNc1cc(F)c(S(=O)(=O)Nc2nccs2)cc1Cl,6.3819519032879075
CHEMBL4102233,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,77.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCCO[C@@H]2c2ccccc2)cc1F,7.113509274827518
CHEMBL4073933,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1300.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCCO[C@H]2c2ccccc2)cc1F,5.886056647693163
CHEMBL4094490,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,50.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCCOC2)cc1F,7.301029995663981
CHEMBL4065325,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6500.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CC1(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)COC1,5.187086643357144
CHEMBL4086750,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1500.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC2CC3(COC3)C2)cc1F,5.823908740944319
CHEMBL4102624,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,52.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=C1CCCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)C1,7.2839966563652006
CHEMBL4084685,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,281.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCC[C@H](O)C2)cc1F,6.55129368009492
CHEMBL4094879,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,151.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCC[C@@H](O)C2)cc1F,6.821023052706831
CHEMBL4074392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,162.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCCC3(C2)OCCO3)cc1F,6.790484985457369
CHEMBL4073324,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,150.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=C1CCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,6.823908740944319
CHEMBL4100176,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,94.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CON=C1CCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,7.026872146400302
CHEMBL4064737,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,444.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCC(=NOCc3ccccc3)CC2)cc1F,6.35261702988538
CHEMBL4092435,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,156.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CC[C@H](O)CC2)cc1F,6.806875401645538
CHEMBL4068484,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,380.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CC[C@@H](O)CC2)cc1F,6.42021640338319
CHEMBL4095822,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,407.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCC3(CC2)OCCO3)cc1F,6.39040559077478
CHEMBL4098747,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,348.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCC3(CC2)OCCO3)cc1F,6.458420756053419
CHEMBL4071739,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6400.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S1(=O)CCC(Nc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,5.1938200260161125
CHEMBL4075332,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,37.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S1(=O)CCC(CCNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,7.431798275933005
CHEMBL4082252,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,266.0,nM,CHEMBL4046487,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -60 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S1(=O)CCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)C1,6.575118363368933
CHEMBL4104727,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18300.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@]23CCO[C@H]2OCC3)cc1F,4.73754891026957
CHEMBL4071860,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12800.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@@]23CCCO[C@@H]2OCC3)cc1F,4.892790030352131
CHEMBL4071736,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,750.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@]23CCC[C@@]2(O)CCC3)cc1F,6.1249387366083
CHEMBL4089301,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19400.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CC4CC(C2)C(O)C(C4)C3)cc1F,4.7121982700697735
CHEMBL4101414,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3200.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCOC2)cc1F,5.494850021680094
CHEMBL4076229,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCOC2)cc1F,5.0
CHEMBL4073353,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,800.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCCC2CCOC2)cc1F,6.096910013008056
CHEMBL4100208,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4500.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCCO2)cc1F,5.346787486224656
CHEMBL4102647,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4000.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCOCC2)cc1F,5.3979400086720375
CHEMBL4084713,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CC1CC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC(C)O1,5.721246399047171
CHEMBL4064762,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2400.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCOCC2)cc1F,5.619788758288394
CHEMBL4092463,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3900.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCCCO2)cc1F,5.4089353929735005
CHEMBL4087220,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3200.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2COCCO2)cc1F,5.494850021680094
CHEMBL4065798,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3700.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCCCO2)cc1F,5.431798275933005
CHEMBL4099769,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7700.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC2CCCOC2)cc1F,5.113509274827518
CHEMBL4072883,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6400.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCCOC2)cc1F,5.1938200260161125
CHEMBL4092025,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5000.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@@H]2CCCOC2)cc1F,5.301029995663981
CHEMBL4094490,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2000.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCCC2CCCOC2)cc1F,5.698970004336019
CHEMBL4065325,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14800.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CC1(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)COC1,4.8297382846050425
CHEMBL4102624,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4700.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=C1CCCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)C1,5.327902142064282
CHEMBL4084685,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3500.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCC[C@H](O)C2)cc1F,5.455931955649724
CHEMBL4094879,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1800.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CCC[C@@H](O)C2)cc1F,5.7447274948966935
CHEMBL4074392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6100.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCCC3(C2)OCCO3)cc1F,5.214670164989233
CHEMBL4073324,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2700.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=C1CCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,5.568636235841012
CHEMBL4100176,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3600.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,CON=C1CCC(CNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,5.443697499232712
CHEMBL4064737,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6700.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCC(=NOCc3ccccc3)CC2)cc1F,5.173925197299173
CHEMBL4092435,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1300.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CC[C@H](O)CC2)cc1F,5.886056647693163
CHEMBL4068484,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,730.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NC[C@H]2CC[C@@H](O)CC2)cc1F,6.136677139879544
CHEMBL4095822,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3200.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC2CCC3(CC2)OCCO3)cc1F,5.494850021680094
CHEMBL4075332,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6000.0,nM,CHEMBL4046488,B,Inhibition of human Nav1.5 inactivated state form expressed in HEK293 cells at -50 mV holding potential by by automated patch clamp electrophysiology assay,CHEMBL4043185,IC50,O=S1(=O)CCC(CCNc2cc(F)c(S(=O)(=O)Nc3nccs3)cc2Cl)CC1,5.221848749616356
CHEMBL3934179,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1500.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,O=S(=O)(Nc1ccncn1)c1ccc2c(c1)OCCN2c1ccc(C(F)(F)F)cc1C1=CCNCC1,5.823908740944319
CHEMBL3928121,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4600.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3ccncn3)ccc21,5.337242168318426
CHEMBL3906169,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1500.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.823908740944319
CHEMBL3983724,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2000.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,COc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,5.698970004336019
CHEMBL3963432,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14000.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,COc1cc(C#N)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)ccc21,4.853871964321762
CHEMBL3919149,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2100.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2c1ccc(S(=O)(=O)Nc1nccs1)c2F,5.6777807052660805
CHEMBL3948638,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,650.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)cc(F)c21,6.187086643357144
CHEMBL3950353,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,320.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)c(F)cc21,6.494850021680094
CHEMBL3907025,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,610.0,nM,CHEMBL4055940,B,Inhibition of human NaV1.5 expressed in HEK295 cells at holding potential of -125 mV with test potentials to -10 mV by whole cell voltage clamp method,CHEMBL4052683,IC50,N#Cc1cc(C(F)(F)F)ccc1N1CCOc2cc(S(=O)(=O)Nc3nccs3)c(Cl)cc21,6.214670164989233
CHEMBL4129030,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11000.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,CS(=O)(=O)NC(=O)c1cc(F)c(COc2ccc(Cl)c(Cl)c2)cc1F,4.958607314841775
CHEMBL4127331,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1800.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,CC(C)COc1ncc(-c2cc(F)c(-c3nnc(S(=O)(=O)C4CCC4)[nH]3)cc2F)cc1Cl,5.7447274948966935
CHEMBL4128718,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,29000.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,CC(C)COc1ncc(-c2ccc(-c3nnc(S(=O)(=O)C4CCC4)[nH]3)cc2F)cc1Cl,4.537602002101044
CHEMBL4128578,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5300.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,COc1cc(-c2nnc(S(=O)(=O)C3CCC3)[nH]2)ccc1-c1cnc(OCC(C)C)c(Cl)c1,5.275724130399211
CHEMBL4129942,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,COc1cc(-c2nnc(S(=O)(=O)C3CCC3)[nH]2)c(F)cc1-c1cnc(OCC(C)C)c(Cl)c1,5.958607314841775
CHEMBL4130058,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2600.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,COc1cc(-c2nnc(S(=O)(=O)N3CCC3)[nH]2)ccc1-c1cnc(OCC(C)C)c(Cl)c1,5.585026652029182
CHEMBL4126793,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7300.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,CC(C)COc1ncc(-c2cc(F)c(-c3nnc(S(=O)(=O)NC4CC4)[nH]3)cc2F)cc1Cl,5.136677139879544
CHEMBL4127756,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10000.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,CC(C)COc1ncc(-c2cc(F)c(-c3nnc(S(=O)(=O)CC4CC4)[nH]3)cc2F)cc1Cl,5.0
CHEMBL4126375,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4000.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,O=S(=O)(CC1CC1)c1nnc(-c2cc(F)c(-c3cnc(Oc4ccc(F)cc4Cl)c(Cl)c3)cc2F)[nH]1,5.3979400086720375
CHEMBL4126519,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1300.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,Cc1ccc(Cl)c(Oc2ncc(-c3cc(F)c(-c4nnc(S(=O)(=O)CC5CC5)[nH]4)cc3F)cc2Cl)c1,5.886056647693163
CHEMBL4129799,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12000.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,O=S(=O)(CC1CC1)c1nnc(-c2cc(F)c(-c3cnc(Oc4ccc(F)cc4F)c(Cl)c3)cc2F)[nH]1,4.920818753952375
CHEMBL4130208,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13000.0,nM,CHEMBL4122429,B,Inhibition of human Nav1.5 expressed in HEK cells at holding potential of -50 mV followed by voltage step to -120 mV by PatchXpress electrophysiology assay,CHEMBL4118149,IC50,O=S(=O)(CC1CC1)c1nnc(-c2cc(F)c(-c3cnc(Oc4ccccc4C(F)(F)F)c(Cl)c3)cc2F)[nH]1,4.886056647693163
CHEMBL4127190,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18000.0,nM,CHEMBL4122826,B,Inhibition of human Nav1.5 expressed in HEK293 cells at -80 mV holding potential after 5 mins by patch clamp assay,CHEMBL4118169,IC50,C[C@]12CCCC[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,4.7447274948966935
CHEMBL4128079,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL4122826,B,Inhibition of human Nav1.5 expressed in HEK293 cells at -80 mV holding potential after 5 mins by patch clamp assay,CHEMBL4118169,IC50,C[C@]12CCC(F)(F)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,4.568636235841013
CHEMBL4129002,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,29000.0,nM,CHEMBL4122826,B,Inhibition of human Nav1.5 expressed in HEK293 cells at -80 mV holding potential after 5 mins by patch clamp assay,CHEMBL4118169,IC50,C[C@]12CC[C@H](C(F)F)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,4.537602002101044
CHEMBL4164272,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3072.0,nM,CHEMBL4158633,B,Inhibition of human Nav1.5 expressed in HEK293 cells at holding potential of -20 mV after 10 mins by patchxpress-based electrophysiology assay,CHEMBL4152382,IC50,C#CC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N3)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC2=O,5.512578788640526
CHEMBL4169884,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,260.0,nM,CHEMBL4158633,B,Inhibition of human Nav1.5 expressed in HEK293 cells at holding potential of -20 mV after 10 mins by patchxpress-based electrophysiology assay,CHEMBL4152382,IC50,C#CC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](Cc4c[nH]c5ccc(Br)cc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N3)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC2=O,6.585026652029182
CHEMBL4159169,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6640.0,nM,CHEMBL4158633,B,Inhibition of human Nav1.5 expressed in HEK293 cells at holding potential of -20 mV after 10 mins by patchxpress-based electrophysiology assay,CHEMBL4152382,IC50,C#CC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](Cc4c[nH]c5ccc(Br)cc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N3)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC2=O,5.1778319206319825
CHEMBL45816,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,500.0,nM,CHEMBL4181848,B,Inhibition of human heart Nav1.5 expressed in HEK293 cells by whole cell voltage clamp method,CHEMBL4177680,IC50,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,6.301029995663981
CHEMBL1627,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,483.0,nM,CHEMBL4184688,B,Inhibition of human Nav1.5 channel expressed in HEK293 cells at holding potential of -70 mV by whole cell patch clamp assay,CHEMBL4184096,IC50,CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,6.316052869248487
CHEMBL841,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,239.0,nM,CHEMBL4184688,B,Inhibition of human Nav1.5 channel expressed in HEK293 cells at holding potential of -70 mV by whole cell patch clamp assay,CHEMBL4184096,IC50,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,6.621602099051863
CHEMBL4224739,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,79.0,nM,CHEMBL4220011,B,Inhibition of Nav1.5 (unknown origin) expressed in xenopus oocytes at -80 mV holding potential by two-electrode voltage-clamp method,CHEMBL4219045,IC50,CSCC[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]3CSSC[C@H](NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)O)CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC3=O)C(=O)N2,7.102372908709558
CHEMBL4226210,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4800.0,nM,CHEMBL4223826,B,Inhibition of neonatal Nav1.5 in human MDA-MB-231 cells assessed as reduction in inward sodium peak current at -100 mV holding potential after 5 to 10 mins by whole cell patch clamp method,CHEMBL4219233,IC50,Fc1ccc(C(CCCNCCCN2CCCCC2)c2ccc(F)cc2)cc1,5.318758762624412
CHEMBL4229014,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5900.0,nM,CHEMBL4223826,B,Inhibition of neonatal Nav1.5 in human MDA-MB-231 cells assessed as reduction in inward sodium peak current at -100 mV holding potential after 5 to 10 mins by whole cell patch clamp method,CHEMBL4219233,IC50,Fc1ccc(CCCCNCCCN2CCCCC2)cc1,5.229147988357855
CHEMBL4279180,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18347.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,CC(C)COc1ncc(-c2cn(C)c3cc(C(=O)NS(C)(=O)=O)ccc23)cc1Cl,4.7364349390391425
CHEMBL4283748,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15105.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,Cn1cc(-c2cnc(OCC3CC3)c(Cl)c2)c2ccc(C(=O)NS(=O)(=O)C3CC3)cc21,4.820879270390701
CHEMBL4294322,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5673.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,CCS(=O)(=O)NC(=O)c1ccc2c(-c3cnc(OCC(C)C)c(Cl)c3)cn(C)c2c1,5.246187216435298
CHEMBL4280298,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6508.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,CC(C)COc1ncc(-c2nn(C)c3cc(C(=O)NS(C)(=O)=O)ccc23)cc1Cl,5.186552455735178
CHEMBL4287506,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3697.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,CC(C)COc1ccc(-c2cn(C)c3cc(C(=O)NS(=O)(=O)C4CC4)c(F)cc23)cn1,5.432150549426893
CHEMBL4292013,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,Cn1cc(-c2ccc(C(F)(F)F)cc2)c2cc(F)c(C(=O)NS(C)(=O)=O)cc21,4.522878745280337
CHEMBL4290933,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3818.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,Cn1cc(-c2ccc(C(F)(F)F)cc2)c2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc21,5.418164075942352
CHEMBL4276864,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9666.0,nM,CHEMBL4255622,B,Inhibition of Nav1.5 (unknown origin) expressed in HEK293 cells at -40 mV holding potential measured after 600 secs by patch clamp method,CHEMBL4251687,IC50,Cn1cc(-c2ccc(C(F)F)cc2)c2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc21,5.0147532091971385
CHEMBL3617053,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9200.0,nM,CHEMBL4257703,B,Inhibition of human NaV1.5,CHEMBL4257443,IC50,O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)C(c1ccccc1)c1ccccc1,5.036212172654444
CHEMBL4276884,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15800.0,nM,CHEMBL4257703,B,Inhibition of human NaV1.5,CHEMBL4257443,IC50,O=C(NCc1ccc(OC(F)(F)F)c(Cl)c1)c1ccc(S(=O)(=O)Nc2nccs2)c(F)c1,4.801342913045577
CHEMBL4293085,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4870.0,nM,CHEMBL4257703,B,Inhibition of human NaV1.5,CHEMBL4257443,IC50,O=C(NCc1ccc(OC(F)(F)F)c(Cl)c1)c1ccc(S(=O)(=O)Nc2ncns2)c(F)c1,5.3124710387853655
CHEMBL4277264,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL4260965,B,Inhibition of Nav1.5 (unknown origin),CHEMBL4257582,IC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,5.958607314841775
CHEMBL3707218,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,84.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,O=C1N(Cc2ccc(C(F)(F)F)o2)c2ccccc2[C@]12COc1cc3c(cc12)OCO3,7.075720713938118
CHEMBL3544913,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,84000.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,4.075720713938118
CHEMBL2325014,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25000.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,Nc1[nH]ncc1-c1cc(Cl)ccc1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl,4.6020599913279625
CHEMBL3657855,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,49.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.309803919971486
CHEMBL4217988,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2600.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1,5.585026652029182
CHEMBL3662190,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,50.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,CC1(COc2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc2C2CC2)CCC2(CC1)CC2,7.301029995663981
CHEMBL3318132,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,400.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,CSCC[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]3CSSC[C@H](NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)O)CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC3=O)C(=O)N2,6.3979400086720375
CHEMBL4588728,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,800.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,CSCC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC1=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N3)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCCN)NC2=O,6.096910013008056
CHEMBL507974,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1000.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,NC1=N[C@H](O)[C@H]2[C@H]3O[C@]4(O)O[C@@H]([C@@H](O)[C@@]2(N1)[C@@H]4O)[C@]3(O)CO,6.0
CHEMBL501134,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,210.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3CCC(O)(O)[C@]23N1,6.6777807052660805
CHEMBL4547737,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4600.0,nM,CHEMBL4321995,B,Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay,CHEMBL4321785,IC50,CC(=O)OC[C@@H]1NC(=N)N2CCC(O)(O)[C@@]23NC(=N)N[C@@H]13,5.337242168318426
CHEMBL4475999,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,19000.0,nM,CHEMBL4392961,B,Inhibition of Nav1.5 (unknown origin),CHEMBL4392823,IC50,CCCN(CCC)[C@H](c1ccccn1)[C@@H](c1ccccn1)N(CCC)C[C@H](O)CO,4.721246399047171
CHEMBL4551786,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12290.0,nM,CHEMBL4413489,B,Inhibition of NaV1.5 (unknown origin),CHEMBL4411314,IC50,CCOC(=O)N1CC/C(=C\C#Cc2cccc(C)n2)C1,4.910448117113546
CHEMBL4129030,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CS(=O)(=O)NC(=O)c1cc(F)c(COc2ccc(Cl)c(Cl)c2)cc1F,4.958607314841775
CHEMBL3682663,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(C(F)(F)F)c(Cl)c3)nccc2c1,4.568636235841013
CHEMBL4579742,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,14400.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CS(=O)(=O)NC(=O)c1ccc2c(Oc3ccc(Cl)c(C(F)(F)F)c3)nccc2c1,4.841637507904751
CHEMBL4462738,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8700.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(Oc2nccc3cc(C(=O)NS(C)(=O)=O)ccc23)cc1Cl,5.060480747381382
CHEMBL4460250,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)c(F)c2)cc1Cl,4.7447274948966935
CHEMBL4443414,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,23000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2F)cc1Cl,4.638272163982407
CHEMBL4445360,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,32000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2)cc1Cl,4.494850021680094
CHEMBL4470095,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5200.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2c(F)cc(C(=O)NS(C)(=O)=O)cc2F)cc1Cl,5.2839966563652006
CHEMBL4444511,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9500.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2Cl)cc1Cl,5.022276394711152
CHEMBL4459478,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3100.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2C(F)(F)F)cc1Cl,5.508638306165727
CHEMBL4539119,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3700.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2OC(F)(F)F)cc1Cl,5.431798275933005
CHEMBL4467379,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,24000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2C#N)cc1Cl,4.619788758288394
CHEMBL4459717,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Oc2cc(Cl)cc(Cl)c2)c(Cl)c1,5.221848749616356
CHEMBL4547268,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,23700.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Oc2cc(F)ccc2F)c(Cl)c1,4.6252516539898965
CHEMBL4571566,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11600.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Oc2cc(Cl)cnc2OC)c(Cl)c1,4.935542010773082
CHEMBL4458713,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,21000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(OCc2ccc(Cl)cc2)c(Cl)c1,4.6777807052660805
CHEMBL4558539,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,9300.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(OCC2(C)CC2)c(Cl)c1,5.031517051446064
CHEMBL4590389,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17800.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(OC2CCC2)c(Cl)c1,4.749579997691106
CHEMBL4530399,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8900.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Sc2cccc(C)c2)c(Cl)c1,5.050609993355087
CHEMBL4448552,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2500.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(N2CCC[C@H]2C(C)C)c(Cl)c1,5.6020599913279625
CHEMBL4576210,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,2350.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Oc2cc(Cl)cc(Cl)c2)c(C(F)(F)F)c1,5.628932137728263
CHEMBL4532519,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18800.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Oc2cc(Cl)cc(Cl)c2)c(C(F)F)c1,4.72584215073632
CHEMBL4437652,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,16100.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)ccc1-c1cnc(Oc2cc(Cl)cc(Cl)c2)c(C#N)c1,4.79317412396815
CHEMBL4469805,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6900.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)c(F)cc1-c1cnc(Oc2cc(F)ccc2F)c(Cl)c1,5.161150909262744
CHEMBL4459021,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)c(F)cc1-c1cnc(OCC2(C)CC2)c(Cl)c1,4.958607314841775
CHEMBL4564010,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,18000.0,nM,CHEMBL4428884,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 3 to 5 mins at -50 mV holding potential by electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)c(F)cc1-c1cnc(OC2CCC2)c(Cl)c1,4.7447274948966935
CHEMBL4469805,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11900.0,nM,CHEMBL4428917,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as reduction in peak inward current by manual whole cell patch clamp electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)c(F)cc1-c1cnc(Oc2cc(F)ccc2F)c(Cl)c1,4.924453038607469
CHEMBL4469805,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13600.0,nM,CHEMBL4428920,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as tonic block at pulse 1 by ionworks quattro electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)c(F)cc1-c1cnc(Oc2cc(F)ccc2F)c(Cl)c1,4.866461091629782
CHEMBL4469805,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,11400.0,nM,CHEMBL4428924,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as use-dependent block at pulse 26 by ionworks quattro electrophysiology assay,CHEMBL4428053,IC50,COc1cc(C(=O)NS(C)(=O)=O)c(F)cc1-c1cnc(Oc2cc(F)ccc2F)c(Cl)c1,4.943095148663527
CHEMBL4741793,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,42000.0,nM,CHEMBL4714790,B,Inhibition of human Nav1.5 by patch clamp analysis,CHEMBL4706729,IC50,C[C@H](NC(=O)c1cc(C(F)(F)F)nn1C)c1nc(-c2ccnc(C(F)(F)F)c2)no1,4.376750709602099
CHEMBL501701,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL4739475,B,Inhibition of recombinant human Nav1.5alpha expressed in HEK293 cells incubated for 10 mins by voltage clamp method,CHEMBL4732263,IC50,N=C(N)NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N,4.522878745280337
CHEMBL4473654,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,22000.0,nM,CHEMBL4739475,B,Inhibition of recombinant human Nav1.5alpha expressed in HEK293 cells incubated for 10 mins by voltage clamp method,CHEMBL4732263,IC50,N=C(N)NC(=O)c1nc(-c2cc3ccccc3o2)c(N)nc1N,4.657577319177793
CHEMBL3707392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,600.0,nM,CHEMBL4765977,B,Inhibition of NaV1.5 expressed in human HEK293 cells assessed as inhibition of late sodium current at -120 mV resting membrane potential by electrophysiology assay,CHEMBL4765231,IC50,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,6.221848749616356
CHEMBL3707392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,100.0,nM,CHEMBL4765978,B,Inhibition of NaV1.5 expressed in human HEK293 cells assessed as inhibition of late sodium current at -80 mV resting membrane potential by electrophysiology assay,CHEMBL4765231,IC50,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,7.0
CHEMBL3707392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,600.0,nM,CHEMBL4765996,B,Inhibition of NaV1.5 expressed in human HEK293 cells assessed as inhibition of late sodium current at 0.1 Hz frequency by manual patch clamp technique,CHEMBL4765231,IC50,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,6.221848749616356
CHEMBL3707392,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,260.0,nM,CHEMBL4765997,B,Inhibition of NaV1.5 expressed in human HEK293 cells assessed as inhibition of late sodium current at 1 Hz frequency by manual patch clamp technique,CHEMBL4765231,IC50,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,6.585026652029182
CHEMBL4857241,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,92000.0,nM,CHEMBL4809418,B,Inhibition of human Nav1.5 expressed in HEK293 cells by IonWorks patch clamp electrophysiology method,CHEMBL4808184,IC50,Cc1c(N2CC[C@@H](C3(N)CC3)C2)c(F)cc2cc(C(=O)O)c(=O)n(C3CC3)c12,4.036212172654444
CHEMBL4867251,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7830.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1ncns1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.106238237942057
CHEMBL4867340,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1180.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cscn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.928117992693874
CHEMBL4877705,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7140.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1ncccn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.146301788223825
CHEMBL4862578,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25490.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccnn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,4.593630164530732
CHEMBL4859414,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,700.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,6.154901959985743
CHEMBL4870820,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1290.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cc(F)ccn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.889410289700751
CHEMBL4867480,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(Cl)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.958607314841775
CHEMBL4849208,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,25050.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1nncs1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,4.601192269796735
CHEMBL4846327,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4650.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1ncc(F)s1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.332547047110046
CHEMBL4850942,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4320.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1ccccn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.364516253185088
CHEMBL4863596,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,5040.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1ncccc1F)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.297569463554474
CHEMBL4857167,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,13210.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1ccc(F)cn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,4.879097182385473
CHEMBL4855375,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6330.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(C(F)(F)F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,5.198596289982644
CHEMBL4876448,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,680.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2F)cc1F,6.167491087293763
CHEMBL4853170,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,460.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2cccc(F)c2)cc1F,6.337242168318426
CHEMBL4865860,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,610.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)cc2)cc1F,6.214670164989233
CHEMBL4860097,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,470.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)cc2F)cc1F,6.327902142064282
CHEMBL4863095,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,260.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)cc1F,6.585026652029182
CHEMBL4849813,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,240.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(OC2CCN(CC(F)(F)F)CC2c2ccc(F)c(F)c2)cc1F,6.619788758288394
CHEMBL4849813,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,430.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(OC2CCN(CC(F)(F)F)CC2c2ccc(F)c(F)c2)cc1F,6.366531544420413
CHEMBL4862429,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4580.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,N#Cc1cccc([C@H]2CN(CC(F)(F)F)CC[C@@H]2Oc2cc(F)c(S(=O)(=O)Nc3cccc(F)n3)cc2F)c1,5.339134521996131
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,65.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,7.187086643357144
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,39.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,7.4089353929735005
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,170.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,6.769551078621726
CHEMBL4864812,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,31.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1F,7.508638306165727
CHEMBL4850129,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1550.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cnc(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,5.809668301829708
CHEMBL4872374,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,750.0,nM,CHEMBL4813111,B,Inhibition of human Nav1.5 by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cscn1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)cc1F,6.1249387366083
CHEMBL4859414,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,410.0,nM,CHEMBL4813155,B,Inhibition of human Nav1.5 VSD2 R814A mutant by automated voltage clamp electrophysiology,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccccc2)cc1F,6.3872161432802645
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,110.0,nM,CHEMBL4813160,B,Inhibition of human Nav1.5 by V1/2 protocol based analysis,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,6.958607314841775
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,44.0,nM,CHEMBL4813164,B,Inhibition of human Nav1.5 expressed in HEK293 cells by sodium influx assay,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,7.356547323513812
CHEMBL558,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3000.0,nM,CHEMBL4813173,B,Inhibition of Nav1.5 (unknown origin)-mediated late channel current,CHEMBL4811281,IC50,Cc1cccc(C)c1OCC(C)N,5.522878745280337
CHEMBL1404,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7000.0,nM,CHEMBL4813173,B,Inhibition of Nav1.5 (unknown origin)-mediated late channel current,CHEMBL4811281,IC50,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,5.154901959985743
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17.7,nM,CHEMBL4813174,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inhibition of peak channel current at holding potential of -95 mV,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,7.752026733638194
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15.8,nM,CHEMBL4813175,B,Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inhibition of late channel current at holding potential of -95 mV,CHEMBL4811281,IC50,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,7.801342913045577
CHEMBL3657851,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,5.958607314841775
CHEMBL3657932,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,260.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.585026652029182
CHEMBL5082739,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,750.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,O=C(NS(=O)(=O)C1COC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.1249387366083
CHEMBL3657939,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,110.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,O=C(NS(=O)(=O)N1CCOCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.958607314841775
CHEMBL3657938,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1500.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,O=C(NS(=O)(=O)N1CCCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,5.823908740944319
CHEMBL3657855,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,870.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,6.060480747381382
CHEMBL3662226,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1100.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CN(C(c3ccccc3)c3ccccc3)C2)cc1F,5.958607314841775
CHEMBL5091342,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,590.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1F,6.229147988357855
CHEMBL5080891,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,27000.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(Cc3ccc(Cl)cc3)CC2)cc1F,4.568636235841013
CHEMBL5071877,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,17000.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(Cc3ccc(OC(F)(F)F)cc3)CC2)cc1F,4.769551078621726
CHEMBL5082321,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,7000.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(Cc3cc(Cl)cc(Cl)c3)CC2)cc1F,5.154901959985743
CHEMBL5080495,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,6400.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(C(=O)c3cc(Cl)cc(Cl)c3)CC2)cc1F,5.1938200260161125
CHEMBL5082131,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3900.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,CC(C)(c1cc(Cl)cc(Cl)c1)N1CCC(COc2cc(F)c(C(=O)NS(C)(=O)=O)cc2C2CC2)CC1,5.4089353929735005
CHEMBL5079176,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1800.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,C[C@H](c1cc(Cl)cc(Cl)c1)N1CCC(COc2cc(F)c(C(=O)NS(C)(=O)=O)cc2C2CC2)CC1,5.7447274948966935
CHEMBL5094715,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1500.0,nM,CHEMBL5055693,B,Inhibition of human Nav1.5 expressed in HEK293 cells incubated for 1 hr in presence of veratridine and anthropleurin-C by sodium influx assay,CHEMBL5055616,IC50,C[C@@H](c1cc(Cl)cc(Cl)c1)N1CCC(COc2cc(F)c(C(=O)NS(C)(=O)=O)cc2C2CC2)CC1,5.823908740944319
CHEMBL3657855,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,51.0,nM,CHEMBL5055701,B,Inhibition of full length human Nav1.5 expressed in HEK cells by whole cell voltage clamp analysis,CHEMBL5055616,IC50,O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,7.292429823902063
CHEMBL5094715,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,551.0,nM,CHEMBL5055701,B,Inhibition of full length human Nav1.5 expressed in HEK cells by whole cell voltage clamp analysis,CHEMBL5055616,IC50,C[C@@H](c1cc(Cl)cc(Cl)c1)N1CCC(COc2cc(F)c(C(=O)NS(C)(=O)=O)cc2C2CC2)CC1,6.2588484011482155
CHEMBL5193436,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,40000.0,nM,CHEMBL5105856,B,Inhibition of human Nav1.5 at -50 mV holding potential by PatchXpress assay,CHEMBL5104138,IC50,CNC(=O)N(c1ccc(S(=O)(=O)Nc2ncccn2)cn1)c1cc(F)c(-c2ccc(F)c(OC(F)(F)F)c2)cc1OC,4.3979400086720375
CHEMBL5180782,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,29900.0,nM,CHEMBL5108155,B,Inhibition of human NaV1.5 expressed in HEK293 by PatchXpress automated patch clamp assay,CHEMBL5107939,IC50,Cn1cc(-c2cccc(C(=O)Nc3cc(N4CC[C@@H](C(C)(C)O)C4)ncc3C(F)(F)F)n2)cn1,4.52432881167557
CHEMBL5197547,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,30000.0,nM,CHEMBL5108155,B,Inhibition of human NaV1.5 expressed in HEK293 by PatchXpress automated patch clamp assay,CHEMBL5107939,IC50,CC(C)(O)[C@@H]1CCN(c2cnc(C(F)(F)F)c(NC(=O)c3cccc(-c4cnn(CC(F)(F)F)c4)n3)c2)C1,4.522878745280337
CHEMBL5204231,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,12900.0,nM,CHEMBL5117281,B,Inhibition of NaV 1.5 (unknown origin),CHEMBL5113463,IC50,C[C@]1(CN2Cc3nc(-c4ccc(F)cc4)sc3C2)Cn2cc([N+](=O)[O-])nc2O1,4.889410289700751
CHEMBL5172865,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,121000.0,nM,CHEMBL5129831,B,Inhibition of human NaV1.5 channel,CHEMBL5126603,IC50,Cn1nc(C(=O)OCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1COc1cccc([C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1,3.91721462968355
CHEMBL5196634,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,46000.0,nM,CHEMBL5131293,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology recording,CHEMBL5126674,IC50,N=C1N[C@H]2[C@H](CN3C(=O)CCC3=O)NC(=N)N3C[C@H](NC(=O)c4cc(C(F)(F)F)ccc4C(F)(F)F)C(O)(O)[C@]23N1,4.337242168318426
CHEMBL4286792,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,95000.0,nM,CHEMBL5131293,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology recording,CHEMBL5126674,IC50,N=C1N[C@H]2[C@H](CN3C(=O)CCC3=O)NC(=N)N3C[C@H](NC(=O)c4cccc(C(F)(F)F)c4)C(O)(O)[C@]23N1,4.022276394711152
CHEMBL5197755,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,77000.0,nM,CHEMBL5131293,B,Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology recording,CHEMBL5126674,IC50,CC1(C)CCOc2c(C(=O)N[C@H]3CN4C(=N)N[C@@H](CN5C(=O)CNC5=O)[C@@H]5NC(=N)N[C@@]54C3(O)O)cccc21,4.113509274827518
CHEMBL4547737,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,4566.0,nM,CHEMBL5131296,B,Inhibition of recombinant human Nav1.5 expressed in CHO cells by whole cell voltage clamp electrophysiology recording,CHEMBL5126674,IC50,CC(=O)OC[C@@H]1NC(=N)N2CCC(O)(O)[C@@]23NC(=N)N[C@@H]13,5.340464092845783
CHEMBL5196338,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1600.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,N#Cc1ccc(Oc2ccc3c(ccc(=O)n3CCN3CCCCC3)c2)cc1,5.795880017344075
CHEMBL5186480,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,CN1CCN(C(=O)COc2ccc3cc(Oc4ccccn4)ccc3n2)CC1,4.481486060122113
CHEMBL3893530,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)F)cn3)ccc2n1)N1CCNCC1,4.481486060122113
CHEMBL3957193,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CCNCC1,4.481486060122113
CHEMBL3946117,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CCNC(C(F)(F)F)C1,4.481486060122113
CHEMBL3971533,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CCN(CC(F)(F)F)CC1,4.481486060122113
CHEMBL3965189,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(NC1CCOC1)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.481486060122113
CHEMBL3896057,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(N[C@@H]1CCOC1=O)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.481486060122113
CHEMBL3950180,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,31300.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(NC1CCC1)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.504455662453552
CHEMBL3929432,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(N[C@H]1C[C@@H](O)C1)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.481486060122113
CHEMBL3942849,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(NC1CC(F)C1)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.481486060122113
CHEMBL3969113,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(NC1CC(F)(F)C1)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.481486060122113
CHEMBL3939162,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,CS(=O)(=O)CCNC(=O)c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1,4.481486060122113
CHEMBL3935365,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CCC1,4.481486060122113
CHEMBL3934019,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,10200.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CC(F)(F)C1,4.991399828238082
CHEMBL3947741,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,8080.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,CS(=O)(=O)C1CN(C(=O)c2ccc3cc(Oc4ccc(C(F)(F)F)cn4)ccc3n2)C1,5.092588639225414
CHEMBL3896584,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CCCC1,4.481486060122113
CHEMBL3910270,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CC[C@H](F)C1,4.481486060122113
CHEMBL3970885,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,33000.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,O=C(c1ccc2cc(Oc3ccc(C(F)(F)F)cn3)ccc2n1)N1CC[C@@H](F)C1,4.481486060122113
CHEMBL698,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,650.0,nM,CHEMBL5147704,B,Inhibition of human Nav 1.5 expressed in HEK293 cells at -90 mV holding potential by Whole cell voltage clamp electrophysiology assay,CHEMBL5143671,IC50,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,6.187086643357144
CHEMBL79,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,50000.0,nM,CHEMBL5224985,B,Inhibition of human Nav1.5 in inactivated condition by automated patch-clamp assay,CHEMBL5223125,IC50,CCN(CC)CC(=O)Nc1c(C)cccc1C,4.301029995663981
CHEMBL558,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,15000.0,nM,CHEMBL5224985,B,Inhibition of human Nav1.5 in inactivated condition by automated patch-clamp assay,CHEMBL5223125,IC50,Cc1cccc(C)c1OCC(C)N,4.823908740944319
CHEMBL108,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,46800.0,nM,CHEMBL5224988,B,Inhibition of human Nav1.5 at -60 mV holding potential by automated patch-clamp assay,CHEMBL5223125,IC50,NC(=O)N1c2ccccc2C=Cc2ccccc21,4.329754146925876
CHEMBL3544913,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3200.0,nM,CHEMBL5224988,B,Inhibition of human Nav1.5 at -60 mV holding potential by automated patch-clamp assay,CHEMBL5223125,IC50,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,5.494850021680094
CHEMBL3707218,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,84.0,nM,CHEMBL5224991,B,Inhibition of human Nav1.5,CHEMBL5223125,IC50,O=C1N(Cc2ccc(C(F)(F)F)o2)c2ccccc2[C@]12COc1cc3c(cc12)OCO3,7.075720713938118
CHEMBL4471012,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,435.0,nM,CHEMBL5225022,B,Inhibition of human Nav1.5 at -60 mV holding potential by manual patch-clamp assay,CHEMBL5223125,IC50,Cc1nn([C@@H]2CCN([C@H](C)c3cc(Cl)cc(Cl)c3)C2)c2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc12,6.361510743045363
CHEMBL4444707,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,3.2,nM,CHEMBL5225022,B,Inhibition of human Nav1.5 at -60 mV holding potential by manual patch-clamp assay,CHEMBL5223125,IC50,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(Cc3cc(C(F)(F)F)ccc3Cl)CC2)cc1F,8.494850021680094
CHEMBL5272252,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,46170.0,nM,CHEMBL5259991,B,Inhibition of Nav1.5 (unknown origin) by whole-cell patch clamp assay,CHEMBL5257116,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(Cl)c(OCCC2CCC3(CCN(Cc4ccccc4)CC3)C2)cc1F,4.335640125448859
CHEMBL5283106,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,54720.0,nM,CHEMBL5259991,B,Inhibition of Nav1.5 (unknown origin) by whole-cell patch clamp assay,CHEMBL5257116,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(Cl)c(OCCC2CCC3(CCN(Cc4ccsc4)CC3)C2)cc1F,4.2618539112879406
CHEMBL5272355,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,58850.0,nM,CHEMBL5259991,B,Inhibition of Nav1.5 (unknown origin) by whole-cell patch clamp assay,CHEMBL5257116,IC50,O=C(NS(=O)(=O)C1CC1)c1cc(Cl)c(OCCC2(F)CCN(Cc3cc(Cl)cc(Cl)c3)CC2)cc1F,4.230253532820546
CHEMBL3341985,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,1900.0,nM,CHEMBL5264190,B,Inhibition of human Nav1.5 alpha subunit expressed in HEK293 cells co-expressing beta1 subunit at -60 mV holding potential by whole-cell patch voltage clamp electrophysiology recording,CHEMBL5260838,IC50,CS(=O)(=O)NC(=O)c1cc(Cl)c(OCC23CC4CC(CC(C4)C2)C3)cc1F,5.721246399047171
CHEMBL3662077,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,260.0,nM,CHEMBL5264214,B,Inhibition of human Nav1.5 alpha subunit expressed in HEK293 cells co-expressing beta1 subunit at -60 mV holding potential by PatchXpress automated voltage clamp electrophysiology technique,CHEMBL5260838,IC50,CC1(COc2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc2C2CC2)CCC(F)(F)CC1,6.585026652029182
CHEMBL3662190,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,50.0,nM,CHEMBL5264214,B,Inhibition of human Nav1.5 alpha subunit expressed in HEK293 cells co-expressing beta1 subunit at -60 mV holding potential by PatchXpress automated voltage clamp electrophysiology technique,CHEMBL5260838,IC50,CC1(COc2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc2C2CC2)CCC2(CC1)CC2,7.301029995663981
CHEMBL4639128,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,50118.72,nM,CHEMBL5303904,B,Cross screening panel,CHEMBL4630907,IC50,COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1,4.300000029139088
CHEMBL5396961,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,28000.0,nM,CHEMBL5374430,B,Inhibition of human Nav1.5 expressed in HEK293 cells by QPatch voltage clamp assay,CHEMBL5370643,IC50,C[C@@]1(N2CCC(c3cc4cc(NC(=O)C5CC56CC6)ncc4cc3Cl)CC2)COC[C@@H]1O,4.552841968657781
CHEMBL2017291,CHEMBL1980,Sodium channel protein type V alpha subunit,IC50,=,79400.0,nM,CHEMBL5465605,B,Selectivity interaction (BET inhibitor selectivity panel (Human Blocker ionworks assay)) EUB0000102c SCN5A,CHEMBL5465560,IC50,COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12,4.100179497572904
CHEMBL4849813,CHEMBL1980,Sodium channel protein type V alpha subunit,Ki,=,2020.0,nM,CHEMBL4813156,B,Displacement of [3H]BNZA from Nav1.5 (unknown origin),CHEMBL4811281,KI,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(OC2CCN(CC(F)(F)F)CC2c2ccc(F)c(F)c2)cc1F,5.694648630553376
CHEMBL4854735,CHEMBL1980,Sodium channel protein type V alpha subunit,Ki,=,370.0,nM,CHEMBL4813156,B,Displacement of [3H]BNZA from Nav1.5 (unknown origin),CHEMBL4811281,KI,O=S(=O)(Nc1cccc(F)n1)c1cc(F)c(O[C@H]2CCN(CC(F)(F)F)C[C@@H]2c2ccc(F)c(F)c2)c(F)c1,6.431798275933005
CHEMBL3126835,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,29000.0,nM,CHEMBL3128676,B,Inhibition of human NaV1.5 expressed in HEK293 cells by fluorescence-based thallium flux assay,CHEMBL3124792,EC50,CCN1CC2CC(C1)N2C(=O)[C@]12C[C@H]1c1cc(OC)ccc1-c1c(C3CCCCC3)c3ccc(C(=O)NS(=O)(=O)N(C)C)cc3n1C2,4.537602002101044
CHEMBL3126834,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,30000.0,nM,CHEMBL3128676,B,Inhibition of human NaV1.5 expressed in HEK293 cells by fluorescence-based thallium flux assay,CHEMBL3124792,EC50,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,4.522878745280337
CHEMBL4753470,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,1.9,nM,CHEMBL4670565,B,Inhibition of NaV1.5 (unknown origin),CHEMBL4665796,EC50,N=C1N[C@H](O)C2C3OC4(O)O[C@@H]([C@@H](O)C2(N1)[C@@H]4O)[C@]3(O)CO,8.721246399047171
CHEMBL5091679,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,138.3,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,6.859177819890689
CHEMBL5083412,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,149.2,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,6.826231176863351
CHEMBL5091623,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,108.4,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,6.964970717797632
CHEMBL5077579,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,27.8,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,7.555955204081924
CHEMBL5093878,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,132.7,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,6.877129077135565
CHEMBL5082582,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,215.2,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,6.667157733005649
CHEMBL5084333,CHEMBL1980,Sodium channel protein type V alpha subunit,EC50,=,155.6,nM,CHEMBL5037534,B,Modulator activity at human Nav1.5 expressed in Xenopus laevis oocytes assessed as elicitation in sodium current measured after 1 to 4 days by two-electrode voltage clamp assay,CHEMBL5036335,EC50,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCCN)C(=O)N4C[C@@H](O)C[C@H]4C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CCCN4C1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC2=O,6.807990407346329
CHEMBL4471012,CHEMBL1980,Sodium channel protein type V alpha subunit,Kd,=,460.0,nM,CHEMBL4321989,B,Binding affinity to human recombinant Nav1.5 by radioligand binding assay,CHEMBL4321785,KD,Cc1nn([C@@H]2CCN([C@H](C)c3cc(Cl)cc(Cl)c3)C2)c2cc(F)c(C(=O)NS(=O)(=O)C3CC3)cc12,6.337242168318426
CHEMBL4444707,CHEMBL1980,Sodium channel protein type V alpha subunit,Kd,=,370.0,nM,CHEMBL4321989,B,Binding affinity to human recombinant Nav1.5 by radioligand binding assay,CHEMBL4321785,KD,CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2CCN(Cc3cc(C(F)(F)F)ccc3Cl)CC2)cc1F,6.431798275933005
